---
title: 'Medicine üçä‚≠ê'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Anatomy

## Head and Neck

## Back

## Thorax

## Abdomen

## Pelvis and Perineum

## Upper Limb

## Lower Limb

## Neuroanatomy

## Histology

### Epithelial Tissue

### Connective Tissue

### Muslce Tissue

### Nervous Tissue

### Circulatory System

### Lymphoid System

### Endocrine System

### Respiratory System

### Gastrointestinal System

* **Oral cavity**
  * **Mucosa**: Stratified squamous epithelium, lining mucosa (nonkeratinized), masticatory mucosa (keratinized or parakeratinized), specialized mucosa (taste bud)
  * **Lips**: External region (skin), vermilion zone, internal region (mucosal)
  * **Palate**: Hard palate (parakeratinized to keratinized), soft palate (nonkeratinized)
* **Teeth**
  * **Component**: Enamel (from ameloblast), cementum, dentin (from odontoblast), dental pulp (vessels, nerves)
  * **Supporting structure**: Periodontal ligament, gingivae, alveolar bone
* **Tongue**
  * **Mucosa**: Dorsal (keratinized or parakeratinized), ventral (nonkeratinized)
  * **Lingual papillae**: Filiform papillae (keratinized, lack taste buds), fungiform papillae (occasional taste buds), foliate papillae (degerate), circumvallate papillae (anterior to sulcus terminalis, taste buds)
* **GI tract (general)**:
  * **Mucosa**: Epithelium, lamina propria, muscularis mucosae
  * **Submucosa**: Nerve, vessel, Meissner plexus
  * **Muscularis externa**:  Inner circular layer, outer longitudinal layer, Auerbach plexus
  * **External layer**: serosa or adventitia
* **Esophagus**
  * **Mucosa**: Stratified squamous nonkeratinized epithelium, esophageal cardiac glands
  * **Submucosa**: Esophageal glands proper
  * **Muscularis externa**: Upper third (skeletal muscle), middle third (smooth and skeletal muscle), lower third (smooth muscle), sphincter
* **Stomach**
  * **Mucosa**: Simple columnar epithelium, gastric gland
  * **Epithelium**: Surface lining cell (visible mucus)
  * **Gastric gland**: Parietal cell (HCl and intrinsic factor, tubulovesicular system), chief cell (pepsinogen), mucous neck cell (soluble mucus), DNES cell (GI hormone), regenerative cell, three types (fundic gland / cardiac and pyloric gland: coiled glands, lack chief cell) 
  * **Submucosa**: Collagenous, Meissner plexus
  * **Muscularis externa**: Three layer (inner oblique, middle circular, outer longitudinal), pyloric sphincter, Auerbach plexus
  * **External layer**: Serosa
* **Small intestine**
  * **Mucosa**: Simple columnar epithelium, crypt of Lieberkuhn, lymphoid nodules (ileum: Peyer patch), lacteals and capillary loops
  * **Epithelium**: Goblet cell (unicellular exocrine gland, mucinogen), surface absorptive cell (striated border), DNES cell (GI hormone)
  * **Crypt of Lieberkuhn**: Paneth cell (lysozyme, defensin, TNFŒ±), regenerative cell, intermediate cell
  * **Lymphoid nodule**: M cell, plasma cell (IgA)
  * **Submucosa**: Fibroelastic, , Meissner plexus, Brunner gland (duodenum)
  * **Muscularis externa**: Iliocecal sphincter, Auerbach plexus
  * **External layer**: Serosa, adventitia (part of duodenum)
* **Large intestine**
  * **Mucosa**: Simple columnar epithelium (no villi), GALT
  * **Submucosa**: Fibroelastic, Meissner plexus
  * **Muscularis externa**: Teniae, Auerbach plexus
  * **External layer**: Serosa, adventitia (ascending and descending colon)
  * **Anal canal**: Simple cuboidal epithelium - stratified squamous nonkeratinized epithelium - stratified squamous keratinized epithelium
  * **Appendix**: Lymphoid nodule
* **Salivary gland**
  * **Salivary gland acini**: Serous cell, mucous cell, mixed (serous demilune), myoepithelial cell
  * **Salivary gland duct**: Intercalated duct (bicarbonate ions), intralobular (striated) duct, intrelobular duct
  * **Types**: Parotid gland (serous), submandibular gland (mixed, mostly serous), sublingual gland (mixed, mostly mucous)
* **Pancreas**
  * **Pancreatic gland (exocrine)**: Acinar cell (digestive enzyme), centroacinar cell
  * **Pancreatic duct (exocrine)**: Intercalated duct (alkaline fluid), intralobular duct, interlobular duct
  * **Islet of Langerhans (endocrine)**: Œ± cell (glucagon), Œ≤ cell (insulin), Œ¥ cell (somatostatin), Œ¥1 cell (VIP), G cell (gastrin), PP cell (pancreatic polypeptide), Œµ cell (ghrelin)
* **Liver**
  * **Lobule**: Classisic lobule (hexagonal), portal lobule (triangular, bile flow), hepatic acinus (diamond-shaped, blood flow, tree zones)
  * **Structure**: Portal area (portal vein, hepatic artery, bile duct, limiting plate), liver sinudoid (fenestration, lack basal laminae, Kupffer cell), space of Disse (subendothelial, Ito cell), plate of hepatocyte, central vein
  * **Flow**: Blood flow (hepatic artery and portal vein - sinusoid - central vein), bile flow (bile canaliculi, canal of Hering, bile duct), lymph flow
  * **Cell**: Hepatocyte (exocrine, endocrine, metabolism, detoxification, storage), cholangiocyte (bile duct), Kupffer cell (phogocytic), Ito cell (fat-storing, defferentiate to myofibroblast)
* **Gallbladder**
  * **Mucosa**: Simple columnar epithelium
  * **Muscle layer**: Smooth muscle cell
  * **Serosa**
{: .notice--info}

### Urinary System

* **Kidney**
* **Urinary tract**
{: .notice--info}

### Reproductive System

* **Ovary**
* **Fallopian tube**
* **Uterus**
* **Cervix**
* **Placenta**
* **Vagina**
* **Mammary gland**
* **Testes**
* **Genital duct**
* **Accessory genital gland**
* **Penis**
{: .notice--info}

### Nervous System

### Special Sense

## Embryology

# Pharmacology

## Autonomic Nervous Drug

## Central Nervous Drug

<!-- ### Sedative-Hypnotic Drug

### Antiphychotic Drug

### Antidepressant Drug

### Mood Stabilizer

### Parkinson Disease Drug

### Alzheimer Disease Drug

### Antiepileptic Drug

### General Anesthetics

### Local Anesthetics

### Opioid Analgesics

### Drug of Abuse -->

## Autocoid

### Histamine

* **H1 antagonist (1st generation)**
  * **Drug**: Chlorpheniramine, dimenhydrinate, diphenhydramine, doxylamine, meclizine, promethazine
  * **Mechanism**: H1 receptor antagonist (pass BBB)
  * **Indication**: Allergic symptoms, insomnia, motion sickness, nausea and vomiting
  * **Adverse effect**: Sedation, dry mouth, blurred vision, urine retention
* **H1 antagonist (2st generation)**
  * **Drug**: Loratadine, cetirizine, clemastine, fexofenadine, desloratadine
  * **Mechanism**: H1 receptor antagonist (not pass BBB)
  * **Indication**: Allergic rhinitis
* **H2 antagonist**
  * **Drug**: Cimetidine, ranitidine, famotidine, nizatidine
  * **Mechanism**: H2 receptor antagonist
  * **Indication**: Gastric and duodenal ulcer
  * **Adverse effect**: Gynecomastia and impotence (cimetidine), CYP450 inhibitor (cimetidine)
* **Mast cell stabilizer**
  * **Drug**: Cromalyn, nedocromil
  * **Mechanism**: Inhibit histamine release
  * **Indication**: Allergic rhinitis, allergic conjunctivitis
{: .notice--info}

### Serotonin

* **5-HT1A agonist**
  * **Drug**: Buspirone
  * **Mechanism**: 5-HT1A receptor partial agonist
  * **Indication**: Anxiety disorder
  * **Adverse effect**: Dizziness, drowsiness, and nausea
* **5-HT1B/1D agonist**
  * **Drug**: Sumatriptan, rizatriptan, eletriptan, zolmitriptan, almotriptan, frovatriptan, naratriptan
  * **Mechanism**: 5-HT1B/1D receptor agonist (vasoconstriction)
  * **Indication**: Acute migraine, cluster headache
  * **Adverse effect**: Dizziness, drowsiness, chest pain, contraindicated in coronary artery disease
* **5-HT3 antagonist**
  * **Drug**: Ondansetron, granisetron, dolasetron, and palonosetron
  * **Mechanism**: 5-HT3 receptor antagonist (in chemoreceptor trigger zone)
  * **Indication**: Nausea and vomiting prevention (chemotherapy, radiation)
  * **Adverse effect**: Headache, constipation, QT prolongation
{: .notice--info}

### Ergot Alkaloid

* **Ergot Alkaloid**
  * **Drug**: Methylergonovine, ergotamine, dihydroergotamine, brpmocriptine, cabergoline
  * **Mechanism**: Agonist or antagonist on Œ±-adrenoceptors, dopamine receptors, serotonin receptors
  * **Indication**: Postpartum hemorrhage (methylergonovine), migraine (ergotamine, dihydroergotamine), hyperprolactinemia (brpmocriptine, cabergoline)
{: .notice--info}

### Eicosanoid

* **PGE1 agonist**
  * **Drug**: Misoprostol, alprostadil
  * **Mechanism**: PGE1 agonist
  * **Indication**: NSAID-induced ulcer (misoprostol), erectile dysfunction (alprostadil), ductus arteriosus maintenance (alprostadil)
* **PGE2 agonist**
  * **Drug**: Dinoprostone
  * **Mechanism**: PGE2 agonist
  * **Indication**: Pregnancy termination, cervical ripening
* **PGF2Œ± agonist**
  * **Drug**: Carboprost, latanoprost
  * **Mechanism**: PGF2Œ± agonist
  * **Indication**: Pregnancy termination (carboprost), glaucoma (latanoprost)
* **PGI2 agonist**
  * **Drug**: Epoprostenol, treprostinil, iloprost
  * **Mechanism**: PGI2 agonist
  * **Indication**: Pulmonary hypertension
{: .notice--info}

## Cardiovascular Drug

## Renal Drug

## Gastrointestinal Drug

### Peptic Ulcer Drug
* **Antacid**
  * **Drug**: Sodium bicarbonate, calcium carbonate, magnesium hydroxide, aluminum hydroxide
  * **Mechanism**: Neutralize gastric acid
  * **Indication**: Reduce intragastric acidity
  * **Adverse effect**: Sodium bicarbonate: gastric distention and belching, fluid retention, metabolic alkalosis / Calcium carbonate: nausea and belching, metabolic alkalosis / Magnesium hydroxide: diarrhea / Aluminium hydroxide: constipation
* **H2 antagonist**
  * **Drug**: Ranitidine, famotidine, nizatidine, cimetidine
  * **Mechanism**: H2 antagonist, decrease acid secretion
  * **Indication**: Peptic ulcer disease, gastroesophageal reflux disease
  * **Adverse effect**: Drowsiness, gynecomastia (cimetidine)
* **Proton pump inhibitor**
  * **Drug**: Omeprazole, lansoprazole, dexlansoprazole, esomeprazole, pantoprazole, rabeprazole
  * **Mechanism**: Inhibit H/K-ATPase pump (irreversible)
  * **Indication**: Peptic ulcer disease, gastroesophageal reflux disease
  * **Adverse effect**: Hypomagnesemia, clostridium difficile-associated diarrhea
* **Sucralfate**
  * **Drug**: Sucralfate
  * **Mechanism**: Form viscous gel, protect stomach surface
  * **Indication**: Duodenal ulcer
  * **Adverse effect**: Constipation
* **PGE1 analog**
  * **Drug**: Misoprostol
  * **Mechanism**: PGE1 analog, stimulate bicarbonate and mucus production
  * **Indication**: NSAID-induced gastric ulcers
  * **Adverse effect**: Abortion
{: .notice--info}

### Antiemetics

* **M1 antagonist**
  * **Drug**: Scopolamine
  * **Mechanism**: M1 antagonist
  * **Indication**: Motion sickness
* **H1 antagonist**
  * **Drug**: Meclizine, dimenhydrinate
  * **Mechanism**: H1 antagonist
  * **Indication**: Motion sickness, vertigo
* **D2 antagonist**
  * **Drug**: Prochlorperazine, promethazine, droperidol, metoclopromide
  * **Mechanism**: D2 antagonist (prochlorperazine and promethazine: antiadrenergic, anticholinergic, antihistaminic / Metoclopramide: enhanced motility, accelerate gastric emptying)
  * **Indication**: Nausea and vomiting, gastroesophageal reflux (metoclopramide)
  * **Adverse effect**: Extrapyramidal effect, QT prlongation (droperidol), contraindicated in Parkinson disease
* **5-HT3 antagonist**
  * **Drug**: Ondansetron, dolasetron, granisetron, palonosetron
  * **Mechanism**: 5-HT3 antagonist
  * **Indication**: Nausea and vomiting
* **Cannabinoid**
  * **Drug**: Dronabinol, nabilone
  * **Mechanism**: CB1 receptor agonist
  * **Indication**: Nausea and vomiting
* **Benzodiazepine**
  * **Drug**: Lorazepam
  * **Mechanism**: Inhance GABA effect
  * **Indication**: Nausea and vomiting
* **Neurokinin receptor antagonist**
  * **Drug**: Aprepitant, fosaprepitant
  * **Mechanism**: NK1 receptor antagonist
  * **Indication**: Nausea and vomiting
{: .notice--info}

### Constipation Drug

* **Bulk-forming laxative**
  * **Drug**: Bran, psyllium, methylcellulose, polycarbophil
  * **Mechanism**: Absorb water and form bulky gell
  * **Indication**: Chronic constipation
* **Osmotic laxative**
  * **Drug**: Magnesium citrate, magnesium hydroxide, sodium phosphate / lactulose, polyethylene glycol
  * **Mechanism**: Retain water by osmosis
  * **Indication**: Acute and chronic constipation
* **Irritant laxative**
  * **Drug**: Bisacodyl, senna
  * **Mechanism**: Stimulate smooth muscle contraction
  * **Indication**: Occasional constipation
  * **Adverse effect**: Cathartic colon
* **Stool softener**
  * **Drug**: Docusate sodium
  * **Mechanism**: Detergent, mix water and fatty substances
  * **Indication**: Occasional constipation, prevent straining
* **Lubricatin agent**
  * **Drug**: Mineral oil
  * **Mechanism**: Coat fecal content
  * **Indication**: Occasional constipation
  * **Adverse effect**: Rectal discharge, decrease fat-soluble vitamin absorption, lipid pneumonitis
* **Opioid-receptor antagonist**
  * **Drug**: Melhylnaltrexone, naloxegol, naldemedine, and alvimopan
  * **Mechanism**: Opioid receptor antagonist
  * **Indication**: Opiod-induced constipation (not affect analgesic effect)
{: .notice--info}

### Antidiarrheal Drug

* **Opioid agonist**
  * **Drug**: Loperamide, diphenoxylate + atropine, difenoxin + atropine
  * **Mechanism**: Opioid receptor agonist, inhibit peristalsis (no analgesic effect and potential or addiction)
  * **Indication**: Diarrhea
* **Bismuth**
  * **Drug**: Bismuth subsalicylate
  * **Mechanism**: Antisecretory, antimicrobial
  * **Indication**: Diarrhea
  * **Adverse effect**: Fecal discoloratian, tongue discoloration
* **Octreotide**
  * **Drug**: Octreotide
  * **Mechanism**: Somatostatin analog, reduct GI hormone secretino (VIP)
  * **Indication**: Severe diarrhea (carcinoid syndrome)
{: .notice--info}

### Irritable Bowel Syndrome Drug

* **Antispasmodics**
  * **Drug**: Dicyclomine, hyoscyamine
  * **Mechanism**: Conlingergic antagonist
  * **Indication**: Irritable bowel syndrome
* **5-HT3 antagonist**
  * **Drug**: Alsetron
  * **Mechanism**: 5-HT3 antagonist
  * **Indication**: Irritable bowel syndrome (diarrhea)
  * **Adverse effect**: Ischemic colitis
* **Lubiprostone**
  * **Drug**: Lubiprostone
  * **Mechanism**: Stimulate type 2 chloride channel
  * **Indication**: Irritable bowel syndrome (constipation)
  * **Adverse effect**: Dyspnea
* **Linaclotide**
  * **Drug**: Linaclotide
  * **Mechanism**: Increase cGMP, choloride secretion into lumen 
  * **Indication**: Irritable bowel syndrome (constipation)
{: .notice--info}

### Other Gastrointestinal Druug

* **Simethicone**
  * **Drug**: Simethicone
  * **Mechanism**: Alter surface tension, accelerate gas passage
  * **Indication**: Gas retention, bloating
* **Ursodiol**
  * **Drug**: Ursodiol
  * **Mechanism**: Reduce cholesterol synthesis and secretion into bile, dissolve cholesterol stone
  * **Indication**: Noncalcifiad gallbladder stones, primary biliary cirrhosis
* **Pancrelipase**
  * **Drug**: Pancrelipase
  * **Mechanism**: Digestive enzyme replacement
  * **Indication**: Exocrine pancreatic insufficiency (cystic fibrosis, pancreatitis)
* **5-Aminosalicylate**
  * **Drug**: Sulfasalazine, olsalazine, balsalazide
  * **Mechanism**: Decrease prostaglandin and leukotriene synthesis, inhibit NK cells, scavenge free radicals
  * **Indication**: Ulcerative colitis, crohn disease
  * **Adverse effect**: Skin rash
{: .notice--info}

### Obesity Drug

* **Sympathomimetics**
  * **Drug**: Phentermine, diethylpropion, benzphetamine, phendimetrazine
  * **Mechanism**: Stimulate norepinephrine release 
  * **Indication**: Obesity
  * **Adverse effect**: Tachycardia, hypertension, dependence, contraindicated in coronary artery disease
* **Lipase inhibitor**
  * **Drug**: Orlistat
  * **Mechanism**: Lipase inhibitor, inhibit fat digestion
  * **Indication**: Obesity
  * **Adverse effect**: Oily rectal leakage, diarrhea, prevent fat-soluble vitamins absorption, contraindicated in cholestasis and malabsorption syndrome
* **GLP-1 agonist**
  * **Drug**: Liraglutide
  * **Mechanism**: GLP-1 agonist, slow gastric empty 
  * **Indication**: Chronic weight management, type 2 diabetes
* **5-HT2C agonist**
  * **Drug**: Lorcaserin
  * **Mechanism**: 5-HT2C agonist
  * **Indication**: Chronic weight management
{: .notice--info}

## Respiratory Drug

### Asthma and COPD Drug

* **Adrenergic agonist**
  * **Drug**: SABA: albuterol, levalbuterol, terbutaline, metoproterenol / LABA: salmeterol, formoterol, vilanterol
  * **Mechanism**: Œ≤2 agonist
  * **Indication**: Asthma quick relief (SABA), asthma long-term control (LABA)
  * **Adverse effect**: Tremor, increased heart rate and palpitations
* **Methylaxantine**
  * **Drug**: Theophylline / Roflumilast
  * **Mechanism**: Phosphodiesterase inhibitor, relax bronchial smooth muscle (low therapeutic index)
  * **Indication**: Asthma (add-on therapy), COPD
  * **Adverse effect**: Insomnia, nausea and vomiting, arrhythmia and seizure
* **Muscarinic antagonist**
  * **Drug**: Ipratropium (short-acting) / tiotropium, umeclidinium, glycopyrronium (long-acting)
  * **Mechanism**: M3 antagonist
  * **Indication**: COPD maintence, asthma
  * **Adverse effect**: Drug mouth
* **Glugocorticoid**
  * **Drug**: Beclomethasone, triamcinolone, budesonide, flunisolide, fluticasone
  * **Mechanism**: Reduce inflammatory cell, decrease vascular permeaability and mucus production
  * **Indication**: Persistent asthma
  * **Adverse effect**: Oral candidiasis
* **Leukotriene pathway inhibitor**
  * **Drug**: Zafirlukast, montelukast / Zileuton
  * **Mechanism**: Leukotriene-receptor antagonist / 5-Lipoxygenase inhibitor, decrease inflammation and bronchoconstriction
  * **Indication**: Asthma prophylaxis and treatment
  * **Adverse effect**: Hepatotoxicity
* **Anti-IgE antibody**
  * **Drug**: Omalizumab
  * **Mechanism**: Anti-IgE antibod, black IgE binding to mast cell
  * **Indication**: Asthma
  * **Adverse effect**: Anaphylaxis
* **Mast cell stabilizer**
  * **Drug**: Cromolyn
  * **Mechanism**: Mast cell stabilizer
  * **Indication**: Asthma chronic control
  * **Adverse effect**: Dry mouth, throat irritation, cough
{: .notice--info}

### Rhinitis Drug

* **Antihistamine**
  * **Drug**: 1st generation: Diphenhydramine, hydroxyzine, brompheniramine, chlorpheniramine / 2nd generation: Loratadine, cetirizine, fexofenadine
  * **Mechanism**: H1 antagonist
  * **Indication**: Sneezing, itching, rhinorrhea
  * **Adverse effect**: Sedation, anticholingergic effect (1st generation)
* **Adrenergic agonist**
  * **Drug**: Oxymetazoline, phenylephrine, pseudoephedrine
  * **Mechanism**: Œ±1 agonist, constrict nasal mucosa arteriole
  * **Indication**: Nasal congestion
* **Inhaled corticosteroid**
  * **Drug**: Beclomethasone, budesonide, flunisolide, fluticasone, mometasone
  * **Mechanism**: Anti-inflammatory
  * **Indication**: Allergic rhinitis
  * **Adverse effect**: Oral candidiasis
{: .notice--info}

### Cough Drug

* **Antitussive**
  * **Drug**: Codeine, hydrocodone, hydromorphone
  * **Mechanism**: Opioid receptor agonist
  * **Indication**: Cough
* **Expectorant**
  * **Drug**: Guanifenesin
  * **Mechanism**: Stimulate watery mucus production
  * **Indication**: Cough
* **Mucolytics**
  * **Drug**: N-acetylcysteine
  * **Mechanism**: Cleave disulfide bond
  * **Indication**: Cough
{: .notice--info}

## Endocrine Drug

### Hypothalamus Hormone

* **Somatostatin analog**
  * **Drugs**: Octreotide, lantreotide
  * **Mechanism**: Decrease GH
  * **Indication**: Acromegaly, diarrhea (VIPoma), variceal and upper GI bleeding
  * **Adverse effect**: Nausea, gallstone
* **GnRH agonist**
  * **Drugs**: Leuprolide, triptorelin, goserelin, nafarelin, histrelin
  * **Mechanism**: Increase FSH and LH (pulsatile), decrease FSH and LH (chronic)
  * **Indication**: Hormone-dependent cancer (chronic), infertility (pulsatile)
  * **Adverse effect**: Hot flash, gynecomastia, osteoporosis, tumor flare
* **GnRH antagonist**
  * **Drugs**: Cetrorelix, ganirelix, and degarelix
  * **Mechanism**: Decrease FSH and LH
  * **Indication**: Controlled ovarian stimulation, advanced prostate cancer
  * **Adverse effect**: Hot flash
* **Dopamine agonist**
  * **Drugs**: Bromocriptine, cabergoline
  * **Mechanism**: Decrease prolactin
  * **Indication**: Amenorrhea, galactorrhea, infertility

### Pituitary Hormone

* **GH agonist**
  * **Drugs**: Somatropin
  * **Mechanism**: Recombinant GH
  * **Indication**: Growth failure, GH deficiency, cachexia
* **GH antagonist**
  * **Drugs**: Pegvisomant
  * **Mechanism**: GH antagonist
  * **Indication**: Acromegaly
* **FSH agonist**
  * **Drugs**: Urofollitropin, follitropin, menotropin
  * **Mechanism**: Stimulate follicle growth and spermatogenesis
  * **Indication**: Controlled ovarian stimulation, spermatogenesis
  * **Adverse effect**: Thromboembolism, ovarian hyperstimulalion syndrome, multiple birth
* **LH agonist**
  * **Drugs**: hCG
  * **Mechanism**: Stimulate egg release and testosterone production 
  * **Indication**: Ovulation induction, hypogonadotropic hypogonadism, prepubertal cryptorchidism
  * **Adverse effect**: Thromboembolism, ovarian hyperstimulalion syndrome, multiple birth
* **ADH agonist**
  * **Drugs**: Vasopressin, desmopressin
  * **Mechanism**: V1 agonist (increase vascular resistance), V2 agonist (decrease urine volume)
  * **Indication**: Central diabetes indipidus, vasodilatory shock
  * **Adverse effect**: Hyponatremia
* **ADH antagonist**
  * **Drugs**: Tolvaptan, conivaptan, demeclocycline
  * **Mechanism**: V2 antagonist
  * **Indication**: SIADH
  * **Adverse effect**: Osmotic damyelination syndrome
* **Oxytocin agonist**
  * **Drugs**: Oxytocin
  * **Mechanism**: Oxytocin agonist
  * **Indication**: Labor induction, postpartum bleeding
  * **Adverse effect**: Cardiovascular instability, antidiuretic effects
{: .notice--info}

### Sex Hormone

* **Estrogen agonist**
  * **Drugs**: Estradiol, ethinyl estradiol, mestranol
  * **Mechanism**: Estrogen receptor agonist
  * **Indication**: Estrogen replacement, menopausal therapy, contraception
  * **Adverse effect**: Nausea, headache, endometrial cancer, postmenopausal bleeding
* **Selective estrogen receptor modulator**
  * **Drugs**: Clomiphene
  * **Mechanism**: Inhibit negative feedback, increase FSH and LH
  * **Indication**: Ovary dysfunction infertility
  * **Adverse effect**: Hot flash, ovarian enlargement
* **Synthetic androgen**
  * **Drugs**: Danazol
  * **Mechanism**: Antiandrogen, antiestrogenic, antiprogestogenic, decrease FSH and LH
  * **Indication**: Endomatriosis, fibrocystic breast disease
  * **Adverse effect**: Weight gain, acne, hair growth, hepatocellular disease
* **Progestin agonist**
  * **Drugs**: Norethindrone, norgestrel, levonorgestrel, megestrol, medroxyprogesterone, hydroxyprogesterone, norgestimate, desogestrel, drospirenone
  * **Mechanism**: Progestin receptor agonsit
  * **Indication**: Contraception, endometrial cancer, abnormal uterine bleeding, delay menstruation
* **Progestin antagonsit**
  * **Drugs**: Mifepristone
  * **Mechanism**: Progestin receptor antagonist
  * **Indication**: Abortion
  * **Adverse effect**: Abdominal pain, vaginal bleeding
* **Androgen agonist**
  * **Drugs**: Testosterone, methyltestosterone, fluoxymesterone, oxymetholon, nandrolone, oxandrolone
  * **Mechanism**: Androgen receptor agonist
  * **Indication**: Hypogonadism
  * **Adverse effect**: Decreased testicular function, increase hepatic enzyme
* **5Œ±-reductase inhibitor**
  * **Drugs**: Finasteride, dutasteride
  * **Mechanism**: 5Œ±-reductase inhibitor, decrease DHT
  * **Indication**: Benign prostatic hyperplasia, male-pattern baldness
  * **Adverse effect**: Sexual dysfunction
{: .notice--info}

### Adrenocortical Hormone

* **Glucocorticoid**
  * **Drugs**: Short-acting: Cortisol, cortisone / Intermediate-acting: Prednisone, prednisolone, triamcinolone / Long-acting: Betamethasone, dexamethasone
  * **Mechanism**: GR (and MR) agonist
  * **Indication**: Inflammation, replacement therapy, Cushing syndrome diagnosis (dexamethasone)
  * **Adverse effect**: Adrenal suppression, hyperglycemia, osteoporosis, peptic ulcer
* **Mineralcorticoid**
  * **Drugs**: Fludrocortisone
  * **Mechanism**: MR agonist
  * **Indication**: Replacement therapy
  * **Adverse effect**: Hypernatremia, hypokalemia, hypertension
* **Adrenocortical antagonist**
  * **Drugs**: Mitotane
  * **Mechanism**: Adrenolytic
  * **Indication**: Adrenocortical carcinoma
  * **Adverse effect**: Confusion, rash
{: .notice--info}

### Thyroid Hormone

* **Thyroid hormone**
  * **Drugs**: Levothyroxine (T4), liothyronine (T3), liotrix (mix)
  * **Mechanism**: Thyroid hormone
  * **Indication**: Hypothyroidism
  * **Adverse effect**: Nervousness, arrhythmia, infarction, osteoporosis
* **Thioamide**
  * **Drugs**: Propylthiouracil, methimazole
  * **Mechanism**: Inhibit iodide organification (peroxidase), inhibit T4/T3 conversion
  * **Indication**: Hyperthyroidism
  * **Adverse effect**: Rash, agranulocytosis
* **Iodide**
  * **Drugs**: Iodide
  * **Mechanism**: Decrease thyroid hormone (Wolff-Chaikolff effect), decrease thyroid size and vascularity
  * **Indication**: Before thyroid surgery
* **Radioactive iodide**
  * **Drugs**: Sodium iodide I-131
  * **Mechanism**: Emit Œ≤ particle, destroy thyroid gland
  * **Indication**: Hyperthyroidism, thyroid carcinoma
   **Adverse effect**: Hypothyroidism
{: .notice--info}

### Glucose Homeostasis

* **Insulin**
  * **Drugs**: Rapid-acting: insulin lispro, insulin aspart, insulin glulisine / Short-acting: regular insulin / Intermediate-acting: NPH / Long-acting: insulin glargine, insulin detemir, insulin degludec
  * **Mechanism**: Insulin
  * **Indication**: Diabetes mellitus (type 1 and 2)
  * **Adverse effect**: Hypoglycemia (tachycardia, sweating, confusion), kypokelemia, weight gain
* **Sulfonylurea**
  * **Drugs**: 1st generation: tolbutamide, chlorpropamide, tolazamide / 2nd generation: glyburide, glipizide, glimepiride
  * **Mechanism**: Block ATP-sensitive K channel, increase insulin secretion
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: Hypoglycemia, weight gain, sulfa allergy
* **Meglitinide**
  * **Drugs**: Rapaglinide, nateglinide
  * **Mechanism**: Block ATP-sensitive K channel, increase insulin secretion
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: Hypoglycemia
* **GLP-1 agonist**
  * **Drugs**: Exenatide, liraglutide, lixisenatide, albiglutide, dulaglutide
  * **Mechanism**: GLP-1 analog, increase glucose-dependent insulin secretion
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: GI distress, acute pancreatitis, thyroid tumor
* **DPP-4 inhibitor**
  * **Drugs**: Sitagliptin, saxagliptin, linagliptin
  * **Mechanism**: DPP-4 inhibitor, increase incretin (GLP-1)
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: Rhinitis, pancreatitis
* **Biguanide**
  * **Drugs**: Metformin
  * **Mechanism**: Reduce hepatic gluconeogenesis, increase insulin sensitivity
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: GI distress, lactic acidosis
* **Thiazolidinedione**
  * **Drugs**: Pioglitazone, rosiglitazone
  * **Mechanism**: Activate PPARŒ≥, decrease insulin resistance
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: Edema, weight gain, fracture, congestive heart failure
* **Œ±-glucosidase inhibitor**
  * **Drugs**: Acarbose, miglitol
  * **Mechanism**: Œ±-glucosidase inhibitor, decrease intestinal glucose absorption
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: GI distress
* **SGLT2 inhibitor**
  * **Drugs**: Canagliflozin, empagliflozin, dapagliflozin
  * **Mechanism**: SGLT2 inhibitor, increase renal glocose excretion
  * **Indication**: Diabetes mellitus (type 2)
  * **Adverse effect**: Genitourinary infection, serum potassium
* **Amylin analog**
  * **Drugs**: Pramlintide
  * **Mechanism**: Amylin analog
  * **Indication**: Diabetes mellitus (type 2)
{: .notice--info}

### Calcium Homeostasis

* **Parathyroid hormone**
  * **Drugs**: Teriparatide
  * **Mechanism**: Stimulate osteoblast (pulsatile)
  * **Indication**: Osteoporosis
  * **Adverse effect**: Hypercalcemia
* **Calcitonin**
  * **Drugs**: Calcitonin
  * **Mechanism**: Antagonize PTH
  * **Indication**: Paget disease, postmenopausal osteoporosis
* **Vitamin D**
  * **Drugs**: Cholecalciferol (vitamin D3), ergocalciferol (vitamin D2)
  * **Mechanism**: Increase intestinal Ca absorption, increase kidney Ca reabsorption
  * **Indication**: Elevate serum Ca
* **Bisphosphonate**
  * **Drugs**: Etidronate / Alendronate, ibandronate, risedronate, zoledronic acid, pamidronate
  * **Mechanism**: Inhibit osteoclast, inhibit farnesyl diphosphate synthase
  * **Indication**: Osteoporosis
  * **Adverse effect**: Esophageal or gastric irritation, osteonecrosis of jaw
* **Anti-RANKL antibody**
  * **Drugs**: Denosumab
  * **Mechanism**: Anti-RANKL antibody, inhibit osteoclast
  * **Indication**: Osteoporosis
* **Calcimimetic**
  * **Drugs**: Cinacalcet
  * **Mechanism**: Activate calcium-sening receptor, reduce PTH
  * **Indication**: Hyperparathyroidism
{: .notice--info}

### Retinoic Acid

* **Tropical tretinoin**
  * **Drugs**: Tretinoin
  * **Mechanism**: Modify epithelial growth and turnover
  * **Indication**: Acne, photo-aged skin, acute promyelocytic leukemia
  * **Adverse effect**: Sunburn
* **Isotretinoin**
  * **Drugs**: Isotretinoin
  * **Mechanism**: Reduce sebaceous gland size
  * **Indication**: Severe cystic acne
  * **Adverse effect**: Teratogenic
* **Acitretin**
  * **Drugs**: Acitretin
  * **Mechanism**: Inhibit proinflammatory cytokine expression
  * **Indication**: Psoriases
  * **Adverse effect**: Skin and nail abnormality, teratogenic
{: .notice--info}

## Hematologic Drug

### Anemia Drug

* **Iron**
  * **Drug**: Iron agents
  * **Mechanism**: Heme synthesis
  * **Indication**: Iron deficienc anemia
  * **Adverse effect**: Gastrointestinal distress, black tarry stool, allergy, acute iron toxicity (treated by deferoxamine)
* **Vitamin B12**
  * **Drug**: Cyanocobalamin, hydroxocobalamin
  * **Mechanism**: DNA synthesis
  * **Indication**: Megaloblastic anemia (pernicious anemia), gastrectomy
* **Folic acid**
  * **Drug**: Folic acid
  * **Mechanism**: DNA synthesis
  * **Indication**: Megaloblastic anemia, prevent fetes neural tube defect 
* **Hydroxyurea**
  * **Drug**: Hydroxyurea
  * **Mechanism**: Increase fetal hemoglobin
  * **Indication**: Sickle cell disease
  * **Adverse effect**: Myelosuppression
* **Erythropoietin**
  * **Drug**: Epoetin alfa, darbepoetin alfa
  * **Mechanism**: Increase RBC
  * **Indication**: Anemia (chronic kidney disease, chemotherapy)
  * **Adverse effect**: Hypertension, thrombosis, hemoglobinemia, tumor progression
* **Thrombopoietin**
  * **Drug**: Romiplostim
  * **Mechanism**: Increase platelet
  * **Indication**: Immune thrombocytopenia
* **G-CSF**
  * **Drug**: Filgrastim, pegfilgrastim
  * **Mechanism**: Increase neutrophils
  * **Indication**: Neutropenia (chemotherapy)
  * **Adverse effect**: Bone pain
* **GM-CSF**
  * **Drug**: Sargramostim
  * **Mechanism**: Increase neutrophils, eosinophils, monocytes, macrophages
  * **Indication**: Neutropenia (chemotherapy), mobilize peripheral blood progenitor (bone marrow donation)
  * **Adverse effect**: Bone pain
{: .notice--info}

### Anticoagulants

* **Heparin**
  * **Drug**: Heparin / enoxaparin, daltaparin / fondaparinux (parenteral)
  * **Mechanism**: ATIII-mediated inhibition of factor Xa and thrombin (heparin only)
  * **Indication**: Deep vein thrombosis, pulmonary embolism, acute coronary syndrome
  * **Adverse effect**: Bleeding (heparin reversed by protamine), heparin-induced thrombocytopenia, monitor by aPTT
* **Warfarin**
  * **Drug**: Warfarin
  * **Mechanism**: Inhibit vitamin K epoxide reductase (inhibit synthesis of factor II, VII, IX, X, protein C, protein S)
  * **Indication**: Deep vein thrombosis, pulmonary embolism,
  * **Adverse effect**: Transient hypercoagulable state, bleeding (reversed by vitamin K), monitor by INR, contraindicated in pregnancy, interacted with drugs affecting CYP2C9 and CYP3A4
* **Direct Xa inhibitor**
  * **Drug**: Rivaroxaban, apixaban, edoxaban, betrixaban (oral)
  * **Mechanism**: Directly bind factor Xa
  * **Indication**: Prevent stroke in atrial fibrillation
  * **Adverse effect**: Bleeding (reversed by andexanet alfa)
* **Direct thrombin inhibitor**
  * **Drug**: Bivalirudin, desirudin, argotroban (parenteral) / Dabigatran (oral)
  * **Mechanism**: Directly bind thrombin 
  * **Indication**: Percutaneous coronary intervention, heparin-induced thrombocytopenia, deep vein thrombosis, pulmonary embolism
  * **Adverse effect**: Bleeding (dabigatran reversed by idarucizumab)
{: .notice--info}

### Antiplatelets

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inhibit COX-1 (irreversible), decrease thromboxane A2
  * **Indication**: Coronary artery disease, stroke
  * **Adverse effect**: Bleeding
* **PDE inhibitor**
  * **Drug**: Dipyridamole, cilostazol
  * **Mechanism**: Inhbit phosphodiesterase, increase cAMP, cause vasodilation and inhibit platelet aggregation 
  * **Indication**: Stroke (dipyridamole), intermittent claudication (cilostazol)
* **P2Y12 inhibitor**
  * **Drug**: Clopidogral, prasugrel, ticagralor, cangrelor
  * **Mechanism**: Bind ADP receptor, inhibit platelet aggregation
  * **Indication**: Coronary artery disease, stroke
  * **Adverse effect**: Bleeding, interact with PPI
  * **Adverse effect**: Bleeding
* **GPIIb/IIIa inhibitor**
  * **Drug**: Abciximab, eptifibatide, tirofiban
  * **Mechanism**: Bind GPIIb/IIIa, inhibit fibrinogen binding, inhibit platelet aggregation
  * **Indication**: Percutaneous coronary intervention, coronary artery disease
  * **Adverse effect**: Bleeding
* **Thrombin receptor antagonist**
  * **Drug**: Vorapaxar
  * **Mechanism**: Thrombin receptor antagonist, inhibit platelet aggregation
  * **Indication**: Coronary artery disease
  * **Adverse effect**: Bleeding
{: .notice--info}

### Thrombolytic Drug

* **Tissue plasminogen activator**
  * **Drug**: Alteplase, tenecteplase
  * **Mechanism**: Form plasmin, lyse thrombi
  * **Indication**: Myocardial infarction, stroke
  * **Adverse effect**: Bleeding
{: .notice--info}

### Hemostatic Drug

* **Vitamin K1**
  * **Drug**: Vitamin K1
  * **Indication**: Newborns, warfarin bleeding
* **Coagulation factor**
  * **Drug**: Factor VIII, factor IX, thrombin
  * **Indication**: Hemophilia A, Hemophilia B
* **Desmopressin**
  * **Drug**: Desmopressin
  * **Mechanism**: Increase factor VIII
  * **Indication**: Hemophilia A
* **Aminocaproic acid**
  * **Drug**: Aminocaproic acid, tranexamic acid
  * **Mechanism**: Inhibit plasminogen activation
  * **Indication**: Hemophilia, postsurgical bleeding
{: .notice--info}

## Immunologic Drug

### NSAID

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inactivate COX-1 and COX-2 (irreversible)
  * **Indication**: Inflammation, pain, fever, reduce thrombi formation, cutaneous infection (topical)
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, renal inpairment, Reye syndrome (during viral infection)
* **NSAID**
  * **Drug**: Ibuprofen, naproxen, fenoprofen, ketoprofen, indomethacin, sulindac, ketorolac, and diclofenac, peroxicam, mefenamate, meclofenamate, nabumetone, celecoxib (COX-2 selective)
  * **Mechanism**: Inactivate COX-1 and COX-2 (reversible)
  * **Indication**: Inflammation, pain, fever
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, renal inpairment, cardiovascular event (COX-2 selective)
* **Acetaminophen**
  * **Drug**: Acetaminophen
  * **Mechanism**: Inactivate COX (centrally acting)
  * **Indication**: Pain, fever
  * **Adverse effect**: Mild increase in hepatic enzyme, toxicity (via NAPQI)
{: .notice--info}

### Gout Drug

* **Colchicine**
  * **Drug**: Colchicine
  * **Mechanism**: Prevent tubulin polymerization, interfere neutrophil migration
  * **Indication**: Acute gouty arthritis
  * **Adverse effect**: Gatrointestinal distress
* **Porbenecid**
  * **Drug**: Compatitively inhibits reabaorption
of urate
  * **Mechanism**: Chronic gout
  * **Indication**: Urolithiasis
  * **Adverse effect**: Reduct other drugs excretion (penicillin)
* **Allopurinol**
  * **Drug**: Allopurinol, feboxostat
  * **Mechanism**: Xanthine oxidase inhibitor
  * **Indication**: Chronic gout
  * **Adverse effect**: Skin rash, GI distress
* **Pegloticase**
  * **Drug**: Pegloticase
  * **Mechanism**: Recombinant uricase
  * **Indication**: Chronic gout
  * **Adverse effect**: Anaphylaxis
{: .notice--info}

### Immunosuppressive Drug

* **Calcineurin inhibitor**
  * **Drug**: Cyclosporine, tacralimus
  * **Mechanism**: Calcineurin inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Nephrotoxicity, hypertension, gingival hyperplasia (cyclosporine)
* **mTOR inhibitor**
  * **Drug**: Sirolimus
  * **Mechanism**: mTOR inhibitor
  * **Indication**: Solid-organ transplant
  * **Adverse effect**: Anemia, impaired wound healing, increased cholesterol
* **Antimetabolite**
  * **Drug**: Azathioprine, mycophenolate mofetil, leflunomide
  * **Mechanism**: Inhibit DNA synthesis (Azathioprine: converted to 6-MP and incorporated, inhibit purine synthesis / Mycophenolate mofetil: inhibit inosine monophosphate dehydrogenase, inhibit purine synthesis / Leflunomide: inhibit dihydroorotate dehydrogenase, inhibit pyrimidine synthesis)
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: GI distress, leukopenia, interact with allopurinol (azathioprine)
* **Biologic agent (TNF-Œ±)**
  * **Drug**: Infliximab, adalimumab, certolizumab, golimumab, and etanercept
  * **Mechanism**: Block TNF-Œ± 
  * **Indication**: Autoimmune diseases
  * **Adverse effect**: Tuberculosis ,lymphoma
* **Biologic agent (IL-1)**
  * **Drug**: Anakinra
  * **Mechanism**: IL-1 receptor antagonist
  * **Indication**: Rheumatold arthritis
  * **Adverse effect**: Infection
* **Biologic agent (IL-6 receptor)**
  * **Drug**: Tocilizumab
  * **Mechanism**: IL-6 receptor antagonist
  * **Indication**: Rheumatold arthritis
  * **Adverse effect**: Increased cholesterol
* **Biologic agent (JAK-STAT)**
  * **Drug**: Tofacitinib
  * **Mechanism**: Block JAK-STAT signaling
  * **Indication**: Rheumatold arthritis
  * **Adverse effect**: Increased cholesterol
* **Biologic agent (CD80/86)**
  * **Drug**: Abatacept
  * **Mechanism**: Block costimulatory signal
  * **Indication**: Rheumatold arthritis
  * **Adverse effect**: Infection
* **Biologic agent (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20 antibody
  * **Indication**: Rheumatoid arthritis, leukemia and lymphoma
  * **Adverse effect**: Infusion reactions, hepatitis B reactivation
* **Biologic agent (CD25)**
  * **Drug**: Basiliximab
  * **Mechanism**: Anti-CD25 antibody
  * **Indication**: Acute transplant rejection
  * **Adverse effect**: Hypertension, infection
* **Biologic agent (Œ±4 integrin)**
  * **Drug**: Natalizumab
  * **Mechanism**: Anti-Œ±4 integrin antibody
  * **Indication**: Multiple sclerosis, Crohn disease.
  * **Adverse effect**: Progressive multifocal leukoencephalopathy
* **Antithymocyte globulin**
  * **Drug**: Antithymocyte globulin
  * **Mechanism**: Elimination of T lymphocyte
  * **Indication**: Aplastic anemia, graft-versus-host disease
  * **Adverse effect**: Serum sickness
{: .notice--info}

## Antineoplastic Drug

### Alkylating Agent

* **Nitrogen mustard**
  * **Drug**: Cyclophosphamide, ifosfamide
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hemorrhagic cystitis (due to acrolein, prevented by masna)
* **Nitrosoureas**
  * **Drug**: Carmustine, lomustine
  * **Mechanism**: Directly damage DNA
  * **Indication**: Brain tumor (cross BBB)
  * **Adverse effect**: Myelosuppression, pulmonary toxicity
* **Alkyl sulfonate**
  * **Drug**: Busfulfan
  * **Mechanism**: Directly damage DNA
  * **Indication**: Before bone marrow transplantation
  * **Adverse effect**: Myelosuppression, pulmonary fibrosis, hyperpigmentation
* **Platinum analog**
  * **Drug**: Cisplatin, carboplatin, oxaliplatin
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various tumor
  * **Adverse effect**: Myelosuppresion, nephrotoxicity, peripheral neuropathy, otoxicity
{: .notice--info}

### Antimetabolte

* **Methotrexate**
  * **Drug**: Methotrexate
  * **Mechanism**: Inhibit dihydrofolate reductase
  * **Indication**: Leukemia and lymphoma, autoimmune disease
  * **Adverse effect**: Myelosuppresion, mucositis, nephrotoxicity, rescued by leucovorin)
* **Pemetrexed**
  * **Drug**: Pemetrexed
  * **Mechanism**: Inhibit thymidylate synthetase, inhibit dihydrofolate reductase (S phase)
  * **Indication**: Mesothelioma, non-small cell lung cancer
  * **Adverse effect**: Myelosuppresion, cutaneous reaction
* **5-Fluorouracil**
  * **Drug**: 5-Fluorouracil, capecitabine
  * **Mechanism**:  Inhibit thymidylate synthetase
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hand-and-foot syndrome
* **Cytarabine**
  * **Drug**: Cytarabine
  * **Mechanism**: Pyrimidine antagonist
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, cerebellar toxicity
* **Gemcitabine**
  * **Drug**: Gemcitabine
  * **Mechanism**: Pyrimidine antagonist
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
* **6-Mercaptopurine**
  * **Drug**: 6-Mercaptopurine, 6-thioguanine
  * **Mechanism**: Purine antagonist
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, interact with allopurinol
* **Cladribine**
  * **Drug**: Cladribine
  * **Mechanism**: Purine antagonist
  * **Indication**: Hairy cell leukemia
  * **Adverse effect**: Myelosuppression
* **Hydroxyuria**
  * **Drug**: Hydroxyuria
  * **Mechanism**: Inhibit ribonucleoside diphosphate reductase
  * **Indication**: Leukemia, sickle cell anemia
  * **Adverse effect**: Myelosuppression, GI distress
{: .notice--info}

### Microtubule Damaging Agent

* **Vinca alkaloids**
  * **Drug**: Vinblastine, vincristine, vinorelbine
  * **Mechanism**: Inhibit microtubule polymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, constipation
* **Taxanes**
  * **Drug**: Paclitaxel, docltaxel, cabazitaxel
  * **Mechanism**: Inhibit microtubule depolymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, hypersensitivity (paclitaxel), fluid retention (docetaxel)
{: .notice--info}

### Topoisomerase Inhibitor

* **Topoisomerase I inhibitor**
  * **Drug**: Topotecan, irinotecan
  * **Mechanism**: Topoisomerase I inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, diarrhea, secondary leukemia
* **Topoisomerase II inhibitor**
  * **Drug**: Etoposide
  * **Mechanism**: Topoisomerase II inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
{: .notice--info}

### Antitumor Antibiotics

* **Antrhacyclines**
  * **Drug**: Doxorubicin, daunorubicin, idarubicin, epirubicin
  * **Mechanism**: Inhibit topoisomerase II, intercalate between DNA base pairs, form oxygen free radical
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, cardiotoxicity (dexrazoxane protect)
* **Dactinomycin**
  * **Drug**: Dactinomycin
  * **Mechanism**: Intercalate between DNA base pairs
  * **Indication**: Pediatric cancer
  * **Adverse effect**: Myelosuppression
* **Bleomycin**
  * **Drug**: Bleomycin
  * **Mechanism**: Form oxygen free radical
  * **Indication**: Testicular cancer
  * **Adverse effect**: Pulmonary toxicity, hyperpigmentation
{: .notice--info}

### Target Therapy

* **Monoclonal antibody (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20
  * **Indication**: Non-Hodgkin lymphoma, chronic lymphocytic leukemia
  * **Adverse effect**: Infusion-related reaction, mucocutaneous reaction, hepatitis B reactivation
* **Monoclonal antibody (CD30)**
  * **Drug**: Brentuximab vedotin
  * **Mechanism**: Anti-CD30
  * **Indication**: Hodgkin lymphoma
  * **Adverse effect**: Peripheral neuropathy
* **Monoclonal antibody (HER2)**
  * **Drug**: Trastuzumab
  * **Mechanism**: Anti-HER2
  * **Indication**: Breast cancer, gastric cancer
  * **Adverse effect**: Cardiomyopathy
* **Monoclonal antibody (EGFR)**
  * **Drug**: Cetuximab
  * **Mechanism**: Anti-EGFR
  * **Indication**: Metastatic colorectal cancer (KRAS wild-type)
  * **Adverse effect**: Rash
* **Monoclonal antibody (VEGF)**
  * **Drug**: Bevacizumab
  * **Mechanism**: Anti-VEGF (inhibit microvascular growth)
  * **Indication**: Various cancer
  * **Adverse effect**: Hypertension, thrombotic event
* **Immune checkpoint inhibitor (CTLA-4)**
  * **Drug**: Ipilimumab
  * **Mechanism**: Anti-CTLA-4, enhance T-cell activation
  * **Indication**: Melanoma
  * **Adverse effect**: Immune-mediated reaction
* **Immune checkpoint inhibitor (PD-1)**
  * **Drug**: Pembrolizumab, nivolumab, cemiplimab
  * **Mechanism**: Anti-PD-1, enhance T-cell activation
  * **Indication**: Various cancer
  * **Adverse effect**: Immune-mediated reaction
* **Immune checkpoint inhibitor (PD-L1)**
  * **Drug**: Atezolizumab, durvalumab, avelumab
  * **Mechanism**: Anti-PD-L1, enhance T-cell activation
  * **Indication**: Various cancer
  * **Adverse effect**: Immune-mediated reaction
* **Tyrosine kinase inhibitor (BCR-ABL)**
  * **Drug**: Imatinib, dasatinib, nilotinib, and ponatinib
  * **Mechanism**: BCR-ABL inhibitor
  * **Indication**: Leukemia and lymphoma (Philadelphia chromosome-positive) 
  * **Adverse effect**: Peripheral edema, elevated transaminase
* **Tyrosine kinase inhibitor (EGFR)**
  * **Drug**: Gatitinib, erlotinib
  * **Mechanism**: EFGR inhibitor
  * **Indication**: NSCLC
  * **Adverse effect**: Acne
* **Tyrosine kinase inhibitor (BRAF)**
  * **Drug**: Vemurafenib
  * **Mechanism**: BRAF inhibitor
  * **Indication**: Melanoma (BRAF V600E)
  * **Adverse effect**: Photosensitivity, squamous cell carcinoma
* **Immunomodulator**
  * **Drug**: Thalidomide, lenalidomide
  * **Mechanism**: Inhibit prointlammatory cytokines secretion, enhance call-mediated immunity
  * **Indication**: Multiple myeloma
  * **Adverse effect**: Hematologic toxicity, peripheral neuropathy, thromboembolic event, birth defect
{: .notice--info}

### Hormone Therapy

* **Selective estrogen receptor modulator**
  * **Drug**: Tamoxifen, toremifene, raloxifene
  * **Mechanism**: Antiestrogenic in breast
  * **Indication**: Breast cancer (hormone receptor positive), osteoporosis (raloxifene)
  * **Adverse effect**: Hot flash, endomtrial cancer (tamoxifen), thromboembolic event
* **Estrogen receptor antagonist**
  * **Drug**: Fulvestrant
  * **Mechanism**: Estrogen receptor antagonist
  * **Indication**: Breast cancer (hormone receptor positive)
  * **Adverse effect**: Hot flash
* **Aromatase inhibitor**
  * **Drug**: Anastrozole, letrozole, exemestane
  * **Mechanism**: Inhibit aromatase, decrease estrogen
  * **Indication**: Breast cancer
  * **Adverse effect**: Decreased bone mineral density, hypercholesterolemia, contraindicate in premenopausal women
* **GnRH agonist**
  * **Drug**: Leuprolide, triptorelin, goserelin, histrelin
  * **Mechanism**: Suppress LH and FSH, decrease androgen
  * **Indication**: Advanced prostate cancer
  * **Adverse effect**: Hot flash, gynecomastia, sexual dysfunction, tumor flare
* **GnRH antagonist**
  * **Drug**: Degarelix
  * **Mechanism**: Suppress LH and FSH, decrease androgen
  * **Indication**: Advanced prostate cancer
  * **Adverse effect**: Hot flash
* **Androgen synthesis inhibitor**
  * **Drug**: Abiraterone, ketoconazole
  * **Mechanism**: Inhibit testosterone production (inhibit CYP17)
  * **Indication**: Metastatic prostate cancer
  * **Adverse effect**: Hepatotoxicity
* **Androgen receptor antagonist**
  * **Drug**: Flutamide, bicalutamlde, nilutamide / enzalutamide
  * **Mechanism**: Androgen receptor antagonist (1st generation), androgen singaling inhibitor (2nd generation)
  * **Indication**: Advanced prostate cancer
  * **Adverse effect**: Seizure
{: .notice--info}

## Antibiotic Drug

### Antibacterial Drug (Cell Wall Synthesis Inhibitor)

* **Penicillins**
  * **Drug**: Penicillin G, penicillin V, banzathine / Penicillinase-resistant: oxacillin, dicloxacillin, mathicillin, nafcillin / Extended-spectrum: ampicillin, amoxicillin, peperacillin / Œ≤-lactamase inhibitor: clavulanic acid, sulbactam, tazobactam
  * **Mechanism**: Inhibit penicillin-binding protein
  * **Property**: Bactericidal, resistance due to Œ≤-lactamase
  * **Indication**: Various, pseudomonas (piperacillin)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Cephalosporins**
  * **Drug**: 1st generation: cephelexin, cefazolin, cefadroxil / 2nd generation: cefoxitin, cefaclor, cefuroxime, cefotatan, cefprozil / 3rd generation: cetdinir, cefixime, cetotaxime, ceftazidime, caftriaxone / 4th: cefepime / 5th generation: ceftaroline
  * **Mechanism**: Inhibit penicillin-binding protein
  * **Property**: Resistant to penicillinases, penetrate CSF (cefuroxime, 3rd generation)
  * **Indication**: Various, pseudomonas (cefoperazone, ceftazidime, cefepime), gonorrhea (ceftriaxone), MRSA (ceftaroline)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Carbapenems**
  * **Drug**: Imipenem (+ cilastatin: inhibit renal dehydropeptidase), ertapenem, meropenem, doripenem
  * **Mechanism**: Inhibit penicillin-binding protein
  * **Indication**: Various, pseudomonas
  * **Adverse effect**: Hypersensitivity
* **Monobactam**
  * **Drug**: Aztreonam
  * **Mechanism**: Inhibit penicillin-binding protein
  * **Indication**: Gram-negative
* **Glycopeptides**
  * **Drug**: Vancomycin, talavancin, dalbavancin, oritavancin
  * **Mechanism**: Inhibit transglycosylase
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Red man syndrome, nephrotoxicity
* **Daptomycin**
  * **Drug**: Daptomycin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Myopathy
* **Polymyxin**
  * **Drug**: Polymyxin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-negative
  * **Adverse effect**: Nephrotoxicity, neurotoxicity
{: .notice--info}

### Antibacterial Drug (Protein Synthesis Inhibitor)

* **Aminoglycosides**
  * **Drug**: Streptomycin, gentamicin, tabramycin, amikacin, neomycin
  * **Mechanism**: Inhibit 30S ribosomal subunit (interfere initiation, mRNA misreadling)
  * **Property**: Narrow therapeutic range, gram-negative aerobes only (active transport through inner membrane)
  * **Indication**: Streptomycin: plague, brucellosis, mycobacterial infections (combination) / Gentamicin and tabramycin: Enterobacter, Proteus, Pseudomonas, Klebsiel/a, Serratia (synergistically Œ≤-lactam) / Amikacin : severe gram-negative infections / Neomycin: soft tissue infections (topical)
  * **Adverse effect**: Ototoxic, nephrotoxic, neuromuscular blockade
* **Tetracyclines**
  * **Drug**: Tetracycline, demeclocycline, doxycycline, minocycline, tigecycline
  * **Mechanism**: Inhibit 30S ribosomal subunit (prevent tRNA binding)
  * **Indication**: Rickatlsia, chlamydia, mycoplasma, acne vulgaris, helicobacter pylori (combination), SIADH (demeclocycline), MRSA (tigecycline)
  * **Adverse effect**: Photosensitivity, tooth discoloration, calcium impair absorption
* **Macrolides**
  * **Drug**: Erythromycin, clarithromycin, azithromycin, telithromycin
  * **Mechanism**: Inhibit 50S subunit (inhibit aminoacyl tanslocation, inhibi initiation complexes)
  * **Indication**: Erythromycin: gram-positive (patients with an allergy to Œ≤-lactam, Legionella pneumophila, syphilis, Bordetella pertussis / Clarithromycin, azithromycin: community-acquired pneumonia and sinusitis, Mycabacterium avium complex
  * **Adverse effect**: QT prolongation, inhibit CYP450
* **Lincosamide**
  * **Drug**: Clindamycin
  * **Mechanism**: Inhibit 50S subunit (inhibit peptide bond formation)
  * **Indication**: Anaerobic, ance (topical)
  * **Adverse effect**: Diarrhea, psaudomembranous colitis
* **Oxazolidinones**
  * **Drug**: Linezolid
  * **Mechanism**: Inhibit 50S subunit (prevents formation of 70S)
  * **Indication**: Gram-positive, VRE
  * **Adverse effect**: Thrombocytopenia, serotonin syndrome
* **Amphenicol**
  * **Drug**: Chloramphenicol
  * **Mechanism**: Inhibit 50S subunit (inhibit peptidyl transferase)
  * **Indication**: Gram-negative organisms, anaerobes
  * **Adverse effect**: Aplastic anemia, hemolytic anemia (G6PD deficienct), gray baby syndrome
* **Streptogramins**
  * **Drug**: Quinupristin, dalfopristin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: VRE, MRSA, multi drug resistant streptococci
{: .notice--info}

### Antibacterial Drug (DNA Synthesis Inhibitor)

* **Antifolate drug**
  * **Drug**: Trimethoprim + sulfamethoxazole
  * **Mechanism**: Inhibit dihydropteroate synthase (sulfamethoxazole), inhibit dihydrofolate reductase (trimethoprim)
  * **Indication**: Urinary tract infections, pneumocystis pneumonia
  * **Adverse effect**: Hypenensitivity, Stevens-Johnson syndrome, hemolytic reactions (G6PD deficiency)
* **Fluoroquinolones**
  * **Drug**: Ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin
  * **Mechanism**: Inhibit DNA gyrase, inhibit topoisomerase IV
  * **Indication**: Urinary tract infections, respiratory tract infections
  * **Adverse effect**: QT prolongation, tendon rupture, divalent and trivalent cations impair absorption
* **Metronidazole**
  * **Drug**: Metronidazole
  * **Mechanism**: Form free radical, inhibit of DNA synthesis and degradation
  * **Indication**: Trichomonas vaginalis, pseudomembranous colitis
  * **Adverse effect**: Peripheral neuropathy, ditulfiram-like reaction
{: .notice--info}

### Antibacterial Drug (Antimycobacterial)

* **Isoniazid**
  * **Drug**: Isoniazid
  * **Mechanism**: Inhibit mycobactarial call wall synthesis
  * **Indication**: Tuberculosis (combination), prophylaxis
  * **Adverse effect**: Hapatotoxic, peripheral nauropathy (minimized by pyridoxine)
* **Rifampin**
  * **Drug**: Rifampin, rifapentine ,rifabutin
  * **Mechanism**: Inhibits RNA synthesis
  * **Indication**: Tuberculosis (combination), atypical mycobactaria, meningitis
  * **Adverse effect**: Orange-color urine
* **Ethambutol**
  * **Drug**: Ethambutol
  * **Mechanism**: Inhibit arabinosyl transfarase
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Visual disturbance
* **Pyrazinamide**
  * **Drug**: Pyrazinamide
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Hepatotoxicity
* **Dapsone**
  * **Drug**: Dapsone
  * **Mechanism**: Inhibit dihydropteroate synthase
  * **Indication**: Leprosy, pneumocystis pneumonia
  * **Adverse effect**: Hemolysis, methemoglobinemia
{: .notice--info}

### Antifungal Drug

* **Amphotericin B**
  * **Drug**: Amphotericin B
  * **Mechanism**: Bind to ergosterol and form pores
  * **Indication**: Various
  * **Adverse effect**: Infusion-related reactions, nephrotoxicity
* **Azoles**
  * **Drug**: Itraconazole, ketoconazole, miconazole, fluconazole, clotrimazole, voriconazola, isavuconazole, and posaconazole
  * **Mechanism**: Inhibit ergosterol synthesis (inhibit lanosterol 14-Œ±-demethylase)
  * **Indication**: Various
  * **Adverse effect**: Hepatotoxicity
* **Echinocandins**
  * **Drug**: Caspofungin, micafungin, anidulafungin
  * **Mechanism**: Disrupt cell wall (inhibit Œ≤-D-glucan synthesis)
  * **Indication**: Candida, aspergillus
* **Flucytosine**
  * **Drug**: Flucytosine
  * **Mechanism**: Inhibit nucleic acid synthesis (converted to 5-fluorauracil)
  * **Indication**: Cryptococcal meningitis
  * **Adverse effect**: Bone marrow supression
* **Griseofulvin**
  * **Drug**: Griseofulvin
  * **Mechanism**: Prevents spindle formation
  * **Indication**: Dermatophyte
{: .notice--info}

### Antiviral Drug

* **Antiherpetic drug**
  * **Drug**: Acyclovir, valacyclovir, famiciclovir / ganciclovir, valganciclovir / foscarnet / cidofovir
  * **Mechanism**: Inhbit DNA polymerase (acyclovir, valacyclovir, famiciclovir: activated by viral thymidine kinase / ganciclovir, valganciclovir: activated by viral phosphotransferase)
  * **Indication**: HSV, EBV, VZV, CMV
  * **Adverse effect**: Acyclovir, valacyclovir, famiciclovir: renal insufficiency, neurotoxicity / ganciclovir, valganciclovir: neutropania, thrombocytopania / foscarnet: nephrotoxicity / cidofovir: naphrotoxicity, neutropenia
* **Anti-influenza drug**
  * **Drug**: Amantadine, rimantadine / Zanamivir, neltamivir / Baloxavir marboxil
  * **Mechanism**: M2 protein inhibitor / Neuraminidase inhibitor / Polymerase acidic protein inhibitor
  * **Indication**: Influenza, prophylaxis
  * **Adverse effect**: CNS effect (M2 protein inhibitor), GI dysfunction (oseltamivir), bronchospasm (zanamivir)
* **Anti-HCV durg (direct-acting antiviral)**
  * **Drug**: Glecaprevir, grazoprevir, paritaprevir, and simeprevir / Daclatasvir, elbasvir, ledipasvir, ombitasvir, pibrentasvir, velpatasvir / Sofosbubir, dasabuvir
  * **Mechanism**: NS3/4A inhibitor, NS5A inhibitor, NS5B inhibitor
  * **Indication**: HCV
* **Anti-HBV drug**
  * **Drug**: Lamivudine, adefovir, entecavir, tenofovir / interferon alpha
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: HBV
{: .notice--info}

### Antiretroviral Drug

* **Nucleoside reverse transcriptase inhibitor**
  * **Drug**: Tenofovir, abacavir, zidovudine, emtricitabine, lamivudine, didanosine, stavudine
  * **Mechanism**: Competitively inhibit reverse transcriptase (require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: Leukopenia, neuropathy, pancreatitis
* **Nonnucleoside reverse transcriptasa inhibitor**
  * **Drug**: Efavirenz, nevirapine, rilpivirine, etravirine, delavirdine
  * **Mechanism**: Noncompetitively inhibit reverse transcriptase (not require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: GI dysfunction, skin reaction
* **Protease inhibitor**
  * **Drug**: Ritonavir, darunavir, atazanavir, lopinavir
  * **Mechanism**: Inhibit polyprotein cleavage
  * **Indication**: HIV
  * **Adverse effect**: Hyperglycemia, hyparlipidemia lipodystrophy
* **Integrase inhibitor**
  * **Drug**: Raltegravir, elvitegravir, dolutegravir bictegravir.
  * **Mechanism**: Prevent viral DNA integration
  * **Indication**: HIV
* **Fusion inhibitor**
  * **Drug**: Enfuvirtida
  * **Mechanism**: Block viral entry (bind gp41)
  * **Indication**: HIV
* **CCR5 antagonist**
  * **Drug**: Maraviroc
  * **Mechanism**: Block viral entry (bind CCR5)
  * **Indication**: HIV
{: .notice--info}

### Antiparasitic Drug

pass
{: .notice--info}

# Microbiology

## Bacteria

### Gram-Positive Cocci

* **Staphylococcus aureus**
  * **Feature**: Gram (+) cocci, catalase (+), coagulase (+), Œ≤-hemolytic, yellow colony, ferments mannitol
  * **Epidemiology**: Normal flora, contact
  * **Pathogenesis**: Protein A (antiphagocytic), coagulase (form fibrin clot), cytolytic toxin (pore forming), enterotoxin (heat stable), exfoliating toxin (SSS), toxic shock syndrome toxin-1 (superantigen, TSST)
  * **Disease**: Gastroenteritis, infective endocarditis, abscess, toxic shock syndrome, impetigo, scalded skin syndrome, pneumonia, surgical infection, osteomyelitis, septic arthritis
* **Staphylococcus epidermidis**
  * **Feature**: Gram (+) cocci, catalase (+), coagulase (-), novobiocin sensitive
  * **Disease**: Infection of catheter/shunt
* **Staphylococcus saprophyticus**
  * **Feature**: Gram (+) cocci, catalase (+), coagulase (-), novobiocin resistant
  * **Disease**: Urinary tract infection
* **Streptococcus pyogenes**
  * **Feature**: Gram (+) cocci, catalase (-), Œ≤-hemolytic, bacitracin sensitive, PYR (+)
  * **Epidemiology**: Contact, droplet
  * **Pathogenesis**: Hyaluronidase, M-protein (antiphagocytic, AGN), streptolysin O (hemolysin), Streptolysin S (hemolysin)
  * **Disease**:
* **Streptococcus agalactiae**
  * **Feature**:
  * **Pathogenesis**: 
  * **Epidemiology**: 
  * **Disease**:
* **Streptococcus pneumoniae**
  * **Feature**:
  * **Pathogenesis**: 
  * **Epidemiology**: 
  * **Disease**:
* **Viridans Streptococci**
  * **Feature**:
  * **Pathogenesis**: 
  * **Epidemiology**: 
  * **Disease**:
* **Enterococcus faecalis/faecium**
  * **Feature**:
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**:
  * **Treatment**:
{: .notice--info}

### Gram-Positive Rods

* **Bacillus anthracis**
  * **Feature**: Gram (+) rod, spore-forming, aerobic, polypeptide capsule, bioterrorism agent
  * **Epidemiology**: Contact with infected animals, inhalation of spores
  * **Pathogenesis**: Polypeptide capsule (antiphagocytic), protective antigen (LF and EF entry), lethal factor (kill cell), edema factor (adenylate cyclase)
  * **Disease**: Cutaneous anthrax (papule, eschar), pulmonary anthrax (woolsorter‚Äôs disease, life-threatening pneumonia, mediastinal hemorrhagic lymphadenitis), GI anthrax
  * **Treatment**: Ciprofloxacin, doxycycline, toxoid vaccine
* **Bacillus cereus**
  * **Feature**: Gram (+) rod, spore-forming, aerobic
  * **Epidemiology**: Foodborne (fried rice)
  * **Pathogenesis**: Emetic toxin (preformed, fast), diarrheal toxin (produced in vivo, slow)
  * **Disease**: Gastroenteritis, eye infection
  * **Treatment**: Self-limiting
* **Clostridium tetani**
  * **Feature**: Gram (+) rod, spore-forming, anaerobic
  * **Epidemiology**: Puncture wound
  * **Pathogenesis**: Tetanus toxin (carried intra-axonally to CNS, bind ganglioside receptor, block inhibitor neurotransmitter release, muscle spasm)
  * **Disease**: Tetanus (risus sardonicus, opisthotonus, extreme muscle spasms)
  * **Treatment**: Tetanus immune globulin, spasmolytic drug, toxoid vaccine
* **Clostridium botulinum**
  * **Feature**: Gram (+) rod, spore-forming, anaerobic
  * **Epidemiology**: Foodborn
  * **Pathogenesis**: Botulinum toxin (A-B polypeptide neurotoxin, coded by prophage, heat labile, block acetylcholine release, flaccid paralysis)
  * **Disease**: Adult botulism (toxin ingested, in canned food), infant botulism (spore ingested, in dust or honey)
* **Clostridium perfringens**
  * **Feature**: Gram (+) rod, spore-forming, anaerobic, stormy fermentation, double zone hemolysis
  * **Epidemiology**: Foodborne, trauma
  * **Pathogenesis**: Alpha toxin (lecithinase, identified by Nagler reaction), enterotoxin (food poisoning)
  * **Disease**: Gas gangrene (wound comtamination, acute pain, tense tissue, fever, high mortality), food poisoning (reheated meat)
  * **Treatment**: Dibridement, clindamycin, hyperbaric chamber
* **Clostridium difficile**
  * **Feature**: Gram (+) rod, spore-forming, anaerobic
  * **Epidemiology**: Endogenous
  * **Pathogenesis**: Toxin A (enterotoxin), toxin B (cytotoxin)
  * **Disease**: antibiotic-associated diarrhea, pseudomembranous colitis
  * **Treatment**: Metronidazole, vancomycin, fecal transplant, discontinuation of antibiotic
* **Listeria monocytogenes**
  * **Feature**: Gram (+) rod, nonspore-forming, Œ≤-hemolytic, tumbling motility, facultative intracellular, cold growth
  * **Epidemiology**: Food borne (unpasteurized milk products), vertical
  * **Pathogenesis**: Listeriolysin O (egress from phagosome into cytoplasm), actin jet (to another cell)
  * **Disease**: Listeriosis (septicemia and meningitis) (in pregnant women, neonatal, immunocompromised)
  * **Treatment**: Ampicillin
* **Corynebacterium diphtheriae**
  * **Feature**: Gram (+) rod, nonspore-forming
  * **Epidemiology**: Droplet
  * **Pathogenesis**: Non invasive, diphtheria toxin (A-B component, coded by prophage, adding ADP-ribose to eEF-2, inhibit protein synthesis)
  * **Disease**: Diphtheria (pseudomembrane, bull neck, myocarditis, recurrent laryngeal nerve palsy)
  * **Treatment**: Erythromycin, antitoxin, toxoid vaccine
* **Actinomyces israelii**
  * **Feature**: Gram (+) branching rod, anaerobic, non-acid fast
  * **Epidemiology**: Endogenous (ginviva, ginital tract)
  * **Pathogenesis**: Invasive growth
  * **Disease**: Actinomycosis (draining abscess, sulfur granule) (cervicofacial, pelvic, brain abscess)
  * **Treatment**: Penicillin V, surgical drainage
* **Nocardia asteroides/brasiliensis**
  * **Feature**: Gram (+) branching rod, aerobic, partially acid fast
  * **Epidemiology**: Airborne, trauma
  * **Pathogenesis**: Immunosuppression
  * **Disease**: Nocardiosis (pulmonary, cutaneous)
  * **Treatment**: TMP-SMX
{: .notice--info}

Mycobacterium tuberculosis
Mycobacterium leprae

### Gram-Negative Cocci

* **Neisseria meningitidis**
* **Neisseria gonorrhoeae**
* **Moraxella catarrhalis**
{: .notice--info}

### Gram-Negative Bacilli

* **Pseudomonas aeruginosa**
* **Legionella pneumophila**
* **Francisella tularensis**
* **Bordetella pertussis**
* **Brucella Species**
* **Haemophilus influenzae**
* **Haemophilus ducreyi**
* **Pasteurella multocida**
* **Campylobacter jejuni**
* **Helicobacter pylori**
* **Vibrio cholerae**

### Enterobacteriaceae

* **Escherichia coli**
  * **Feature**: Gram (-) rod, falcultative anartobe, oxidase negative, ferment lactose
  * **Epidemiology**: Endogenous, fecal-oral
  * **Pathogenesis**: 
  * **Disease**: Urinary tract infection, neonatal septicemia and meningitis, septicemia, gastroenteritis (ETEC: traveler's dirrhea, EPEC: infantile diarrhea, EIEC, EAEC, EHEC: )
  * **Treatment**: 
* **Klebsiella pneumoniae**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Shigella Species**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Yersinia pestis**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Yersinia enterocolitica**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Proteus mirabilis/vulgaris**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Salmonella enterica typhi**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Salmonella enteritidis/typhimurium**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Gardnerella vaginalis**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:
* **Bacteroides fragilis**
  * **Feature**: 
  * **Epidemiology**: 
  * **Pathogenesis**: 
  * **Disease**: 
  * **Treatment**:

## Spirochetes

{: .notice--info}


## Virus

### DNA Virus

* **Parvovirus**
{: .notice--info}

### Hepatitis Virus

## Fungus

## Parasite

# Cardiology / Âæ™Áí∞Âô®Áßë

<!-- ## Heart Failure / ÂøÉ‰∏çÂÖ®

### Left-Sided Heart Failure / Â∑¶ÂøÉ‰∏çÂÖ®
### Right-Sided Heart Failure / Âè≥ÂøÉ‰∏çÂÖ®

## Arrhythmia / ‰∏çÊï¥ËÑà

### Sinus Tachycardia / Ê¥ûÊÄßÈ†ªËÑà
### Paroxysmal Supraventricular Tachycardia / Áô∫‰ΩúÊÄß‰∏äÂÆ§È†ªÊãç
### Wolff-Parkinson-White Syndrome / WPWÁóáÂÄôÁæ§
### Atrial Flutter / ÂøÉÊàøÁ≤óÂãï
### Atrial Fibrillation / ÂøÉÊàøÁ¥∞Âãï
### Atrial Premature Contraction / ÂøÉÊàøÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Premature Contraction / ÂøÉÂÆ§ÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Tachycardia / ÂøÉÂÆ§È†ªÊãç
### Ventricular Fibrillation / ÂøÉÂÆ§Á¥∞Âãï
### Long QT Syndrome / QTÂª∂Èï∑ÁóáÂÄôÁæ§
### Brugada Syndrome / BrugadaÁóáÂÄôÁæ§
### Sick Sinus Syndrome / Ê¥û‰∏çÂÖ®ÁóáÂÄôÁæ§
### Atrioventricular Block / ÊàøÂÆ§„Éñ„É≠„ÉÉ„ÇØ
### Bundle Branch Block / ËÑö„Éñ„É≠„ÉÉ„ÇØ

## Ischemic Heart Disease / ËôöË°ÄÊÄßÂøÉÁñæÊÇ£

### Effort Angina Pectoris / Âä¥‰ΩúÊÄßÁã≠ÂøÉÁóá
### Vasospastic Angina Pectoris / ÂÜ†Êî£Á∏ÆÊÄßÁã≠ÂøÉÁóá
### Unstable Angina Pectoris / ‰∏çÂÆâÂÆöÁã≠ÂøÉÁóá
### Acute Myocardial Infarction / ÊÄ•ÊÄßÂøÉÁ≠ãÊ¢óÂ°û
### Complication of Myocardial Infarction / ÂøÉÁ≠ãÊ¢óÂ°û„ÅÆÂêà‰ΩµÁóá

## Valvular Heart Disease / ÂøÉËáìÂºÅËÜúÁóá

### Mitral Stenosis / ÂÉßÂ∏ΩÂºÅÁã≠Á™ÑÁóá
### Mitral Regurgitation / ÂÉßÂ∏ΩÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Mitral Valve Prolapse / ÂÉßÂ∏ΩÂºÅÈÄ∏ËÑ±Áóá
### Aortic Stenosis / Â§ßÂãïËÑàÂºÅÁã≠Á™ÑÁóá
### Aortic Regurgitation / Â§ßÂãïËÑàÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Tricuspid Stenosis / ‰∏âÂ∞ñÂºÅÁã≠Á™ÑÁóá
### Tricuspid Regurgitation / ‰∏âÂ∞ñÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

## Endocardium, Myocardium and Pericardium Disease / ÂøÉÂÜÖËÜú„ÉªÂøÉÁ≠ã„ÉªÂøÉËÜúÁñæÊÇ£

### Infectious Endocarditis / ÊÑüÊüìÊÄßÂøÉÂÜÖËÜúÁÇé
### Cardiac Myxoma / ÂøÉËáìÁ≤òÊ∂≤ËÖ´
### Dilated Cardiomyopathy / Êã°ÂºµÂûãÂøÉÁ≠ãÁóá
### Hypertrophic Cardiomyopathy / ËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá
### Restrictive Cardiomyopathy / ÊãòÊùüÂûãÂøÉÁ≠ãÁóá
### Takotsubo-Type Cardiomyopathy / „Åü„Åì„Å§„ÅºÂûãÂøÉÁ≠ãÁóá
### Myocarditis / ÂøÉÁ≠ãÁÇé
### Acute Pericarditis / ÊÄ•ÊÄßÂøÉËÜúÁÇé
### Cardiac Tamponade / ÂøÉ„Çø„É≥„Éù„Éä„Éº„Éá
### Constrictive Pericarditis / ÂèéÁ∏ÆÊÄßÂøÉËÜúÁÇé

## Arterial Disease / ÂãïËÑàÁñæÊÇ£

### Arteriosclerosis / ÂãïËÑàÁ°¨Âåñ
### Aortic Aneurysm / Â§ßÂãïËÑàÁò§
### Aortic Dissection / Â§ßÂãïËÑàËß£Èõ¢
### Arterio-Venous Fistula / ÂãïÈùôËÑàÁòª
### Acute Arterial Occlusive Disease / ÊÄ•ÊÄßÂãïËÑàÈñâÂ°ûÁóá
### Arteriosclerosis Obliterans / ÈñâÂ°ûÊÄßÂãïËÑàÁ°¨ÂåñÁóá
### Thromboangiitis Obliterans / ÈñâÂ°ûÊÄßË°ÄÊ†ìË°ÄÁÆ°ÁÇé
### Raynaud Disease / RaynaudÁóÖ

## Venous Disease / ÈùôËÑàÁñæÊÇ£

### Deep Vein Thrombosis / Ê∑±ÈÉ®ÈùôËÑàË°ÄÊ†ìÁóá
### Varicose Vein / ‰∏ãËÇ¢ÈùôËÑàÁò§
### SVC Syndrome / ‰∏äÂ§ßÈùôËÑàÁóáÂÄôÁæ§
### Lymphedema / „É™„É≥„ÉëÊµÆËÖ´

## Blood Pressure Disorder / Ë°ÄÂúßÁï∞Â∏∏

### Essential Hypertension / Êú¨ÊÖãÊÄßÈ´òË°ÄÂúßÁóá
### Secondary Hypertension / ‰∫åÊ¨°ÊÄßÈ´òË°ÄÂúßÁóá
### Malignant Hypertension / ÊÇ™ÊÄßÈ´òË°ÄÂúßÁóá
### Hypotension / ‰ΩéË°ÄÂúß -->

# Pulmonology/ ÂëºÂê∏Âô®Áßë

<!-- ## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Acute Bronchiolitis / ÊÄ•ÊÄßÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Community-Acquired Pneumonia / Â∏Ç‰∏≠ËÇ∫ÁÇé
### Hospital-Acquired Pneumonia / Èô¢ÂÜÖËÇ∫ÁÇé
### Aspiration Pneumonia / Ë™§Âö•ÊÄßËÇ∫ÁÇé
### Streptococcus Penumoniae Pneumonia / ËÇ∫ÁÇéÁêÉËèåËÇ∫ÁÇé
### Haemophilus Influenzae Pneumonia / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåËÇ∫ÁÇé
### Klebsiella Pneumoniae Pneumonia / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ËÇ∫ÁÇé
### Staphylococcus Aureus Pneumonia / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåËÇ∫ÁÇé
### Moraxella Catarrhalis Pneumonia / „É¢„É©„ÇØ„Çª„É©ËÇ∫ÁÇé
### Pseudomonas Aeruginosa Pneumonia / Á∑ëËÜøËèåËÇ∫ÁÇé
### Legionella Pneumophila Pneumonia / „É¨„Ç∏„Ç™„Éç„É©ËÇ∫ÁÇé
### Mycoplasma Pneumoniae Pneumonia / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûËÇ∫ÁÇé
### Chlamydophila Pneumoniae Pneumonia / „ÇØ„É©„Éü„Ç∏„Ç¢ËÇ∫ÁÇé
### Psittacosis / „Ç™„Ç¶„É†ÁóÖ
### Viral Pneumonia / „Ç¶„Ç§„É´„ÇπÊÄßËÇ∫ÁÇé
### Lung Abscess / ËÇ∫ËÜøÁòç
### Pulmonary Tuberculosis / ËÇ∫ÁµêÊ†∏
### Miliary Tuberculosis / Á≤üÁ≤íÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Simple Pulmonary Aspergilloma / ÂçòÁ¥îÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É≠„Éº„Éû
### Chronic Progressive Pulmonary Aspergillosis / ÊÖ¢ÊÄßÈÄ≤Ë°åÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Invasive Pulmonary Aspergillosis / ‰æµË•≤ÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Pulmonary Cryptococcosis / ËÇ∫„ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„Ç´„ÇπÁóá

## Obstructive Lung Disease / ÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

### Chronic Obstructive Pulmonary Disease / ÊÖ¢ÊÄßÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£
### Diffuse Panbronchiolitis / „Å≥„Åæ„ÇìÊÄßÊ±éÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Lymphangioleiomyomatosis / „É™„É≥„ÉëËÑàÁÆ°Á≠ãËÖ´Áóá

## Interstitial Lung Disease / ÈñìË≥™ÊÄßËÇ∫ÁñæÊÇ£

### Idiopathic Pulmonary Fibrosis / ÁâπÁô∫ÊÄßËÇ∫Á∑öÁ∂≠Áóá
### Non-Specific Interstitial Pneumonia / ÈùûÁâπÁï∞ÊÄßÈñìË≥™ÊÄßËÇ∫ÁÇé
### Cryptogenic Organizing Pneumonia / ÁâπÁô∫ÊÄßÂô®Ë≥™ÂåñËÇ∫ÁÇé
### Asbestosis / Áü≥Á∂øËÇ∫
### Silicosis / Áè™ËÇ∫
### Radiation Pneumonitis / ÊîæÂ∞ÑÁ∑öËÇ∫ÁÇé
### Drug-Induced Pneumonia / Ëñ¨Ââ§ÊÄßËÇ∫ÁÇé

## Immune and Allergic Lung Disease / ÂÖçÁñ´„Éª„Ç¢„É¨„É´„ÇÆ„ÉºÊÄßËÇ∫ÁñæÊÇ£

### Bronchial Asthma / Ê∞óÁÆ°ÊîØÂñòÊÅØ
### Aspirin-Induced Asthma / „Ç¢„Çπ„Éî„É™„É≥ÂñòÊÅØ
### Acute Eosinophilic Pneumonia / ÊÄ•ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Chronic Eosinophilic Pneumonia / ÊÖ¢ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Allergic Bronchopulmonary Aspergillosis / „Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÊ∞óÁÆ°ÊîØËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Hypersensitivity Pneumonitis / ÈÅéÊïèÊÄßËÇ∫ÁÇé

## Lung and Bronchus Malformation / ËÇ∫„ÉªÊ∞óÁÆ°ÊîØ„ÅÆÂΩ¢ÊÖãÁï∞Â∏∏
### Bronchiectasis / Ê∞óÁÆ°ÊîØÊã°ÂºµÁóá
### Atelectasis / ÁÑ°Ê∞óËÇ∫
### Pulmonary Sequestration / ËÇ∫ÂàÜÁîªÁóá
### Pulmonary Cystic Disease / ËÇ∫Âö¢ËÉûÁóá
### Pulmonary Alveolar Proteinosis / ËÇ∫ËÉûËõãÁôΩÁóá

## Lung Tumor / ËÇ∫ËÖ´Áòç

### Pulmonary Hamartoma / ËÇ∫ÈÅéË™§ËÖ´
### Squamous Cell Carcinoma / ÊâÅÂπ≥‰∏äÁöÆÁôå
### Adenocarcinoma / ËÖ∫Áôå
### Small Cell Lung Carcinoma / Â∞èÁ¥∞ËÉûËÇ∫Áôå
### Metastatic Lung Tumor / Ëª¢ÁßªÊÄßËÇ∫ËÖ´Áòç

## Pulmonary Circulation Disorder / ËÇ∫Âæ™Áí∞ÈöúÂÆ≥

### Pulmonary Thromboembolism / ËÇ∫Ë°ÄÊ†ìÂ°ûÊ†ìÁóá
### Idiopathic Pulmonary Arterial Hypertension / ÁâπÁô∫ÊÄßËÇ∫ÂãïËÑàÊÄßËÇ∫È´òË°ÄÂúßÁóá
### Cor Pulmonale / ËÇ∫ÊÄßÂøÉ
### Pulmonary Arteriovenous Fistula / ËÇ∫ÂãïÈùôËÑàÁòª
### Pulmonary Edema / ËÇ∫Ê∞¥ËÖ´
### Acute Respiratory Distress Syndrome / ÊÄ•ÊÄßÂëºÂê∏Á™ÆËø´ÁóáÂÄôÁæ§

## Functional Respiratory Disease / Ê©üËÉΩÁöÑÂëºÂê∏ÈöúÂÆ≥

### Hyperventilation Syndrome / ÈÅéÊèõÊ∞óÁóáÂÄôÁæ§
### CO2 Narcosis / CO2„Éä„É´„Ç≥„Éº„Ç∑„Çπ
### Sleep Apnea Syndrome / Áù°Áú†ÊôÇÁÑ°ÂëºÂê∏ÁóáÂÄôÁæ§

## Pleural Disease / ËÉ∏ËÜúÁñæÊÇ£

### Pneumothorax / Ê∞óËÉ∏
### Pleuritis / ËÉ∏ËÜúÁÇé
### Pyothorax / ËÜøËÉ∏
### Chylothorax / ‰π≥„Å≥ËÉ∏
### Pleural Mesothelioma / ËÉ∏ËÜú‰∏≠ÁöÆËÖ´

## Mediastinal Disease / Á∏¶ÈöîÁñæÊÇ£

### Acute Mediastinitis / ÊÄ•ÊÄßÁ∏¶ÈöîÁÇé
### Mediastinal Emphysema / Á∏¶ÈöîÊ∞óËÖ´
### Thymoma / ËÉ∏ËÖ∫ËÖ´
### Neurogenic Tumor / Á•ûÁµåÂéüÊÄßËÖ´Áòç
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç -->

# Gastroenterology / Ê∂àÂåñÂô®Áßë

<!-- 
## Esophageal Disease / È£üÈÅìÁñæÊÇ£

### Achalasia / È£üÈÅì„Ç¢„Ç´„É©„Ç∑„Ç¢
### Gastroesophageal Reflux Disease / ËÉÉÈ£üÈÅìÈÄÜÊµÅÁóá
### Eosinophilic Esophagitis / Â•ΩÈÖ∏ÁêÉÊÄßÈ£üÈÅìÁÇé
### Esophageal Candidiasis / È£üÈÅì„Ç´„É≥„Ç∏„ÉÄÁóá
### Mallory-Weiss Syndrome / Mallory-WeissÁóáÂÄôÁæ§
### Spontaneous Rupture of the Esophagus / ÁâπÁô∫ÊÄßÈ£üÈÅìÁ†¥Ë£Ç
### Esophageal Cancer / È£üÈÅìÁôå
### Esophagogastric Varices / È£üÈÅì„ÉªËÉÉÈùôËÑàÁò§
### Esophageal Diverticulum / È£üÈÅìÊÜ©ÂÆ§

## Gastric and Duodenal Disease / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÁñæÊÇ£

### Acute Gastric Mucosal Lesion / ÊÄ•ÊÄßËÉÉÁ≤òËÜúÁóÖÂ§â
### Chronic Gastritis / ÊÖ¢ÊÄßËÉÉÁÇé
### Functional Dyspepsia / Ê©üËÉΩÊÄß„Éá„Ç£„Çπ„Éö„Éó„Ç∑„Ç¢
### Gastro-Duodenal Ulcer / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞Áòç
### Gastro-Duodenal Ulcer Perforation / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞ÁòçÁ©øÂ≠î
### Gastric Polyp / ËÉÉ„Éù„É™„Éº„Éó
### GIST / Ê∂àÂåñÁÆ°ÈñìË≥™ËÖ´Áòç
### Gastrointestinal Malignant Lymphoma / Ê∂àÂåñÁÆ°ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Gastric Cancer / ËÉÉÁôå
### Dumping Syndrome / „ÉÄ„É≥„Éî„É≥„Ç∞ÁóáÂÄôÁæ§
### Gastro-Duodenal Diverticulum / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊÜ©ÂÆ§
### Superior Mesenteric Artery Syndrome / ‰∏äËÖ∏ÈñìËÜúÂãïËÑàÁóáÂÄôÁæ§
### M√©n√©trier's Disease / M√©n√©trierÁóÖ

## Intestinal and Colonic Disease / Â∞èËÖ∏„ÉªÂ§ßËÖ∏ÁñæÊÇ£

### Crohn's Disease / CrohnÁóÖ
### Ulcerative Colitis / ÊΩ∞ÁòçÊÄßÂ§ßËÖ∏ÁÇé
### Intestinal Tuberculosis / ËÖ∏ÁµêÊ†∏
### Infectious Enterocolitis / ÊÑüÊüìÊÄßËÖ∏ÁÇé
### Pseudomembranous Colitis / ÂÅΩËÜúÊÄßÂ§ßËÖ∏ÁÇé
### Antibiotic-Associated Hemorrhagic Colitis / ÊäóËèåËñ¨Èñ¢ÈÄ£Âá∫Ë°ÄÊÄßÂ§ßËÖ∏ÁÇé
### MRSA Enteritis / MRSAËÖ∏ÁÇé
### Irritable Bowel Syndrome / ÈÅéÊïèÊÄßËÖ∏ÁóáÂÄôÁæ§
### Colonic Polyp / Â§ßËÖ∏„Éù„É™„Éº„Éó
### Colorectal Cancer / Â§ßËÖ∏Áôå
### Lynch Syndrome / LynchÁóáÂÄôÁæ§
### Small Intestine Tumor / Â∞èËÖ∏ËÖ´Áòç
### Gastrointestinal Neuroendocrine Neoplasm / Ê∂àÂåñÁÆ°Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç
### Familial Adenomatous Polyposis / ÂÆ∂ÊóèÊÄßËÖ∫ËÖ´ÊÄß„Éù„É™„Éù„Éº„Ç∑„Çπ
### Peutz-Jeghers Syndrome / Peutz-JeghersÁóáÂÄôÁæ§
### Malabsorption Syndrome / Âê∏Âèé‰∏çËâØÁóáÂÄôÁæ§
### Protein-Losing Gastroenteropathy / ËõãÁôΩÊºèÂá∫ÊÄßËÉÉËÖ∏Áóá
### Ischemic Colitis / ËôöË°ÄÊÄßÂ§ßËÖ∏ÁÇé
### Acute Mesenteric Artery Occlusion / ÊÄ•ÊÄßËÖ∏ÈñìËÜúÂãïËÑàÈñâÂ°ûÁóá
### Occlusive Ileus / ÈñâÂ°ûÊÄßËÖ∏ÈñâÂ°û
### Strangulation Ileus / ÁµûÊâºÊÄßËÖ∏ÈñâÂ°û
### Paralytic Ileus / È∫ªÁó∫ÊÄß„Ç§„É¨„Ç¶„Çπ
### Colonic Diverticulum / Â§ßËÖ∏ÊÜ©ÂÆ§
### Acute Appendicitis / ÊÄ•ÊÄßËô´ÂûÇÁÇé

## Anal Disease / ËÇõÈñÄÁñæÊÇ£

### Hemorrhoids / ÁóîÊ†∏
### Anal Fissure / Ë£ÇËÇõ
### Perianal Abscess / ËÇõÈñÄÂë®Âõ≤ËÜøÁòç
### Anal Fistula / ÁóîÁòª
### Rectal Prolapse / Áõ¥ËÖ∏ËÑ±

## Peritoneal Disease / ËÖπËÜúÁñæÊÇ£

### Inguinal Hernia / Èº†ÂæÑ„Éò„É´„Éã„Ç¢
### Femoral Hernia / Â§ßËÖø„Éò„É´„Éã„Ç¢
### Obturator Hernia / ÈñâÈéñÂ≠î„Éò„É´„Éã„Ç¢
### Abdominal Incisional Hernia / ËÖπÂ£ÅÁò¢Áóï„Éò„É´„Éã„Ç¢
### Umbilical Hernia / Ëáç„Éò„É´„Éã„Ç¢
### Esophageal Hiatal Hernia / È£üÈÅìË£ÇÂ≠î„Éò„É´„Éã„Ç¢
### Acute Peritonitis / ÊÄ•ÊÄßËÖπËÜúÁÇé
### Spontaneous Bacterial Peritonitis / ÁâπÁô∫ÊÄßÁ¥∞ËèåÊÄßËÖπËÜúÁÇé
### Cancerous Peritonitis / ÁôåÊÄßËÖπËÜúÁÇé
### Pseudomyxoma Peritonei / ËÖπËÜúÂÅΩÁ≤òÊ∂≤ËÖ´

## Liver Disease / ËÇùÁñæÊÇ£

### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis B / BÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé
### Acute Viral Hepatitis / ÊÄ•ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Chronic Viral Hepatitis / ÊÖ¢ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Drug-Induced Liver Injury / Ëñ¨Ââ§ÊÄßËÇùÈöúÂÆ≥
### Acute Liver Failure / ÊÄ•ÊÄßËÇù‰∏çÂÖ®
### Fatty Liver / ËÑÇËÇ™ËÇù
### Nonalcoholic Steatohepatitis / Èùû„Ç¢„É´„Ç≥„Éº„É´ÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé
### Alcoholic Liver Disease / „Ç¢„É´„Ç≥„Éº„É´ÊÄßËÇùÈöúÂÆ≥
### Autoimmune Hepatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÇùÁÇé
### Primary Biliary Cholangitis / ÂéüÁô∫ÊÄßËÉÜÊ±ÅÊÄßËÉÜÁÆ°ÁÇé
### Primary Sclerosing Cholangitis / ÂéüÁô∫ÊÄßÁ°¨ÂåñÊÄßËÉÜÁÆ°ÁÇé
### Liver Cirrhosis / ËÇùÁ°¨Â§â
### Hepatocellular Carcinoma / ËÇùÁ¥∞ËÉûÁôå
### Intrahepatic Cholangiocarcinoma / ËÇùÂÜÖËÉÜÁÆ°Áôå
### Metastatic Liver Tumor / Ëª¢ÁßªÊÄßËÇùÁôå
### Hepatic Hemangioma / ËÇùË°ÄÁÆ°ËÖ´
### Hepatic Cyst / ËÇùÂö¢ËÉû
### Liver Abscess / ËÇùËÜøÁòç
### Idiopathic Portal Hypertension / ÁâπÁô∫ÊÄßÈñÄËÑàÂúß‰∫¢ÈÄ≤Áóá
### Budd-Chiari Syndrome / Budd-ChiariÁóáÂÄôÁæ§

## Biliary Disease / ËÉÜÈÅìÁñæÊÇ£

### Cholelithiasis / ËÉÜÁü≥Áóá
### Acute Cholecystitis / ÊÄ•ÊÄßËÉÜÂö¢ÁÇé
### Acute Cholangitis / ÊÄ•ÊÄßËÉÜÁÆ°ÁÇé
### Gallbladder Adenomyomatosis / ËÉÜÂö¢ËÖ∫Á≠ãËÖ´Áóá
### Gallbladder Cancer / ËÉÜÂö¢Áôå
### Bile Duct Cancer / ËÉÜÁÆ°Áôå
### Cancer of Pipilla of Vator / ‰π≥È†≠ÈÉ®Áôå

## Pancreatic Disease / ËÜµÁñæÊÇ£

### Acute Pancreatitis / ÊÄ•ÊÄßËÜµÁÇé
### Chronic Pancreatitis / ÊÖ¢ÊÄßËÜµÁÇé
### Autoimmune Pancreatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÜµÁÇé
### Pancreatic Carcinoma / ËÜµÁôå
### Pancreatic Psuedocyst / ËÜµ‰ªÆÊÄßÂö¢ËÉû
### Intraductal Papillary Mucinous Neoplasm / ËÜµÁÆ°ÂÜÖ‰π≥È†≠Á≤òÊ∂≤ÊÄßËÖ´Áòç
### Mucinous Cystic Neoplasm / Á≤òÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Serous Cystic Neoplasm / ÊºøÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Pancreatic Neuroendocrine Neoplasm / ËÜµÁ•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç -->

# Endocrinology / ÂÜÖÂàÜÊ≥åÁßë

<!-- ## Hypothalamus and Pituitary Gland Disease / Ë¶ñÂ∫ä‰∏ãÈÉ®„Éª‰∏ãÂûÇ‰ΩìÁñæÊÇ£

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá
### Acromegaly / ÂÖàÁ´ØËÇ•Â§ßÁóá
### Cushing's Disease / CushingÁóÖ
### Hypopituitarism / ‰∏ãÂûÇ‰ΩìÂâçËëâÊ©üËÉΩ‰Ωé‰∏ãÁóá
### Central Diabetes Insipidus / ‰∏≠Êû¢ÊÄßÂ∞øÂ¥©Áóá
### SIADH / „Éê„Çæ„Éó„É¨„Ç∑„É≥‰∏çÈÅ©ÂêàÂàÜÊ≥åÁóáÂÄôÁæ§

## Thyroid Gland Disease / Áî≤Áä∂ËÖ∫ÁñæÊÇ£

### Grave's Disease / BasedowÁóÖ
### Plummer Disease / PlummerÁóÖ
### Acute Thyroiditis / ÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Subacute Thyroiditis / ‰∫úÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Painless Thyroiditis / ÁÑ°ÁóõÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Chronic Thyroiditis / ÊÖ¢ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Simple Goiter / ÂçòÁ¥îÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Multinodular Goiter / Â§öÁµêÁØÄÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Thyroid Cancer / Áî≤Áä∂ËÖ∫Áôå

## Parathyroid Gland Disease / ÂâØÁî≤Áä∂ËÖ∫ÁñæÊÇ£

### Primary Hyperparathyroidism / ÂéüÁô∫ÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Renal Hyperparathyroidism / ËÖéÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Malignancy-Related Hypercalcemia / ÊÇ™ÊÄßËÖ´ÁòçÈñ¢ÈÄ£È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypoparathyroidism / ÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Pseudohypoparathyroidism / ÂÅΩÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá

## Adrenal Gland Disease / ÂâØËÖéÁñæÊÇ£

### Cushing's Syndrome / CushingÁóáÂÄôÁæ§
### Primary Aldosteronism / ÂéüÁô∫ÊÄß„Ç¢„É´„Éâ„Çπ„ÉÜ„É≠„É≥Áóá
### Addison's Disease / AddisonÁóÖ
### Acute Adrenal Insufficiency / ÊÄ•ÊÄßÂâØËÖé‰∏çÂÖ®
### Pheochromocytoma / Ë§êËâ≤Á¥∞ËÉûËÖ´

## Other Endocrine Disease / „Åù„ÅÆ‰ªñ„ÅÆÂÜÖÂàÜÊ≥åÁñæÊÇ£

### MEN / Â§öÁô∫ÊÄßÂÜÖÂàÜÊ≥åËÖ∫ËÖ´Áóá
### Insulinoma / „Ç§„É≥„Çπ„É™„Éé„Éº„Éû
### Gastrinoma / „Ç¨„Çπ„Éà„É™„Éé„Éº„Éû
### Glucagonoma / „Ç∞„É´„Ç´„Ç¥„Éé„Éº„Éû
### VIPoma / VIPoma

## Glucose Metabolism Disorder / Á≥ñ‰ª£Ë¨ùÁï∞Â∏∏

### Type 1 Diabetes Mellitus / 1ÂûãÁ≥ñÂ∞øÁóÖ
### Type 2 Diabetes Mellitus / 2ÂûãÁ≥ñÂ∞øÁóÖ
### Maturity-Onset Diabetes of the Young / Ëã•Âπ¥Áô∫ÁóáÊàê‰∫∫ÂûãÁ≥ñÂ∞øÁóÖ
### Gestational Diabetes Mellitis / Â¶äÂ®†Á≥ñÂ∞øÁóÖ
### Diabetic Ketoacidosis / Á≥ñÂ∞øÁóÖÊÄß„Ç±„Éà„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Hyperosmolar Hyperglycemic Syndrome / È´òÊµ∏ÈÄèÂúßÈ´òË°ÄÁ≥ñÁóáÂÄôÁæ§
### Diabetic Foot / Á≥ñÂ∞øÁóÖË∂≥ÁóÖÂ§â
### Hypoglycemia / ‰ΩéË°ÄÁ≥ñÁóá

## Lipid and Nutrition Metabolism Disorder / ËÑÇË≥™„ÉªÊ†ÑÈ§ä‰ª£Ë¨ùÁï∞Â∏∏

### Dyslipidemia / ËÑÇË≥™Áï∞Â∏∏Áóá
### Familial Hypercholesterolemia / ÂÆ∂ÊóèÊÄßÈ´ò„Ç≥„É¨„Çπ„ÉÜ„É≠„Éº„É´Ë°ÄÁóá
### Obesity Disease / ËÇ•Ê∫ÄÁóá
### Metabolic Syndrome / „É°„Çø„Éú„É™„ÉÉ„ÇØ„Ç∑„É≥„Éâ„É≠„Éº„É†
### Vitamin A Deficiency / „Éì„Çø„Éü„É≥AÊ¨†‰πèÁóá
### Vitamin B1 Deficiency / „Éì„Çø„Éü„É≥B1Ê¨†‰πèÁóá
### Vitamin B3 Deficiency / „Éì„Çø„Éü„É≥B3Ê¨†‰πèÁóá
### Vitamin B6 Deficiency / „Éì„Çø„Éü„É≥B6Ê¨†‰πèÁóá
### Vitamin B12 Deficiency / „Éì„Çø„Éü„É≥B12Ê¨†‰πèÁóá
### Vitamin C Deficiency / „Éì„Çø„Éü„É≥CÊ¨†‰πèÁóá
### Vitamin D Deficiency / „Éì„Çø„Éü„É≥DÊ¨†‰πèÁóá
### Vitamin E Deficiency / „Éì„Çø„Éü„É≥EÊ¨†‰πèÁóá
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá
### Zinc Deficiency / ‰∫úÈâõÊ¨†‰πèÁóá
### Copper Deficiency / ÈäÖÊ¨†‰πèÁóá
### Malnutrition Syndrome / Ê†ÑÈ§ä‰∏çËâØÁóáÂÄôÁæ§

## Other Metabolism Disorder / „Åù„ÅÆ‰ªñ„ÅÆ‰ª£Ë¨ùÁï∞Â∏∏

### Hyperuricemia / È´òÂ∞øÈÖ∏Ë°ÄÁóá
### Gout / ÁóõÈ¢®
### Pseudogout / ÂÅΩÁóõÈ¢®
### Osteoporosis / È™®Á≤óÈ¨ÜÁóá
### Osteopetrosis / È™®Á°¨ÂåñÁóá
### Paget's Disease of Bone / È™®PagetÁóÖ
### Hemochromatosis / „Éò„É¢„ÇØ„É≠„Éû„Éà„Éº„Ç∑„Çπ
### Acute Intermittent Porphyria / ÊÄ•ÊÄßÈñìÊ¨†ÊÄß„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Porphyria Cutanea Tarda / Êô©Áô∫ÊÄßÁöÆËÜö„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Amyloidosis / „Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ -->

# Nephrology / ËÖéËáìÁßë

<!-- ## Water and Electrolytes Metabolism Disorder / Ê∞¥„ÉªÈõªËß£Ë≥™‰ª£Ë¨ùÁï∞Â∏∏

### Hyponatremia / ‰Ωé„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypernatremia / È´ò„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypokalemia / ‰Ωé„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hyperkalemia / È´ò„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hypocalcemia / ‰Ωé„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypercalcemia / È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypophosphatemia / ‰Ωé„É™„É≥Ë°ÄÁóá
### Hyperphosphatemia / È´ò„É™„É≥Ë°ÄÁóá
### Hypomagnesemia / ‰Ωé„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypermagnesemia / È´ò„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Metabolic Acidosis / ‰ª£Ë¨ùÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Metabolic Alkalosis / ‰ª£Ë¨ùÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ
### Respiratory Acidosis / ÂëºÂê∏ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Respiratory Alkalosis / ÂëºÂê∏ÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ

## Glomerular Disease / Á≥∏ÁêÉ‰ΩìÁñæÊÇ£

### Acute Glomerulonephritis / ÊÄ•ÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Rapid Progressive Glomerulonephritis / ÊÄ•ÈÄüÈÄ≤Ë°åÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### IgA Nephropathy / IgAËÖéÁóá
### Minimal Change Nephrotic Syndrome / ÂæÆÂ∞èÂ§âÂåñÂûã„Éç„Éï„É≠„Éº„ÇºÁóáÂÄôÁæ§
### Membranous Nephropathy / ËÜúÊÄßËÖéÁóá
### Focal Segmental Glomerulosclerosis / Â∑£Áä∂ÂàÜÁØÄÊÄßÁ≥∏ÁêÉ‰ΩìÁ°¨ÂåñÁóá
### Membranoproliferative Glomerulonephritis / ËÜúÊÄßÂ¢óÊÆñÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Alport's Syndrome / AlportÁóáÂÄôÁæ§
### Benign Familial Hematuria / ËâØÊÄßÂÆ∂ÊóèÊÄßË°ÄÂ∞ø

## Tubulointerstitial Disease / Â∞øÁ¥∞ÁÆ°„ÉªÈñìË≥™ÊÄßÁñæÊÇ£

### Fanconi Syndrome / FanconiÁóáÂÄôÁæ§
### Bartter's Syndrome / BartterÁóáÂÄôÁæ§
### Pseudo-Bartter's Syndrome / ÂÅΩÊÄßBartterÁóáÂÄôÁæ§
### Gitelman's Syndrome / GitelmanÁóáÂÄôÁæ§
### Liddle's Syndrome / LiddleÁóáÂÄôÁæ§
### Nephrogenic Diabetes Insipidus / ËÖéÊÄßÂ∞øÂ¥©Áóá
### Renal Tubular Acidosis / Â∞øÁ¥∞ÁÆ°ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Tubulointerstitial Nephritis / Â∞øÁ¥∞ÁÆ°ÈñìË≥™ÊÄßËÖéÁÇé

## Renal Injury with Systemic Disease / ÂÖ®Ë∫´ÊÄßÁñæÊÇ£„Å´‰º¥„ÅÜËÖéÈöúÂÆ≥

### Diabetic Nephropathy / Á≥ñÂ∞øÁóÖÊÄßËÖéÁóá
### Gouty Kidney / ÁóõÈ¢®ËÖé
### Myeloma Kidney / È™®È´ÑËÖ´ËÖé
### Cryoglobulin Nephropathy / „ÇØ„É™„Ç™„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóáÊÄßËÖéÁóá
### Amyloid Nephropathy / „Ç¢„Éü„É≠„Ç§„ÉâËÖéÁóá
### Lupus Nephritis / „É´„Éº„Éó„ÇπËÖéÁÇé
### Scleroderma Kidney / Âº∑ÁöÆÁóáËÖé
### Drug-Induced Kidney Injury / Ëñ¨Ââ§ÊÄßËÖéÈöúÂÆ≥

## Renal Vascular Disease / ËÖéË°ÄÁÆ°ÊÄßÁñæÊÇ£

### Renovascular Hypertension / ËÖéË°ÄÁÆ°ÊÄßÈ´òË°ÄÂúß
### Benign Nephrosclerosis / ËâØÊÄßËÖéÁ°¨ÂåñÁóá
### Malignant Nephrosclerosis / ÊÇ™ÊÄßËÖéÁ°¨ÂåñÁóá
### Renal Infarction / ËÖéÊ¢óÂ°û
### Renal Papillary Necrosis / ËÖé‰π≥È†≠Â£äÊ≠ª
### Renal Cortical Necrosis / ËÖéÁöÆË≥™Â£äÊ≠ª
### Renal Vein Thrombosis / ËÖéÈùôËÑàË°ÄÊ†ìÁóá

## Renal Failure / ËÖé‰∏çÂÖ®

### Acute Kidney Injury / ÊÄ•ÊÄßËÖéÈöúÂÆ≥
### Chronic Kidney Disease / ÊÖ¢ÊÄßËÖéËáìÁóÖ
### Disequilibrium Syndrome / ‰∏çÂùáË°°ÁóáÂÄôÁæ§
### CKD Mineral and Bone Disorder / CKD„Å´‰º¥„ÅÜÈ™®„Éü„Éç„É©„É´‰ª£Ë¨ùÁï∞Â∏∏
### Dialysis Amyloidosis / ÈÄèÊûê„Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ
### Renal Anemia / ËÖéÊÄßË≤ßË°Ä -->

# Hematology / Ë°ÄÊ∂≤Áßë

<!-- ## Nonhemolytic Anemia / ÈùûÊ∫∂Ë°ÄÊÄßË≤ßË°Ä

### Iron Deficiency Anemia / ÈâÑÊ¨†‰πèÊÄßË≤ßË°Ä
### Sideroblastic Anemia / ÈâÑËäΩÁêÉÊÄßË≤ßË°Ä
### Secondary Anemia / ‰∫åÊ¨°ÊÄßË≤ßË°Ä
### Aplastic Anemia / ÂÜçÁîü‰∏çËâØÊÄßË≤ßË°Ä
### Pure Red Cell Aplasia / Ëµ§ËäΩÁêÉÁôÜ
### Megaloblastic Anemia / Â∑®Ëµ§ËäΩÁêÉÊÄßË≤ßË°Ä

## Hemolytic Anemia / Ê∫∂Ë°ÄÊÄßË≤ßË°Ä

### Hereditary Spherocytosis / ÈÅ∫‰ºùÊÄßÁêÉÁä∂Ëµ§Ë°ÄÁêÉÁóá
### Thalassemia / „Çµ„É©„Çª„Éü„Ç¢
### Sickle Cell Disease / ÈéåÁä∂Ëµ§Ë°ÄÁêÉÁóá
### G6PD Deficiency / G6PDÁï∞Â∏∏Áóá
### Pyruvate Kinase Deficiency / PKÁï∞Â∏∏Áóá
### Paroxysmal Nocturnal Hemoglobinuria / Áô∫‰ΩúÊÄßÂ§úÈñì„Éò„É¢„Ç∞„É≠„Éì„É≥Â∞øÁóá
### Autoimmune Hemolytic Anemia / Ëá™Â∑±ÂÖçÁñ´ÊÄßÊ∫∂Ë°ÄÊÄßË≤ßË°Ä
### Red Cell Fragmentation Syndrome / Ëµ§Ë°ÄÁêÉÁ†¥Á†ïÁóáÂÄôÁæ§

## Leukemia / ÁôΩË°ÄÁóÖ

### Acute Myeloid Leukemia / ÊÄ•ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Acute Lymphoblastic Leukemia / ÊÄ•ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Chronic Myeloid Leukemia / ÊÖ¢ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Chronic Lymphocytic Leukemia / ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Hairy Cell Leukemia / ÊúâÊØõÁ¥∞ËÉûÁôΩË°ÄÁóÖ
### Adult T-cell Leukemia/Lymphoma / Êàê‰∫∫TÁ¥∞ËÉûÁôΩË°ÄÁóÖ„Éª„É™„É≥„ÉëËÖ´

## Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´

### Hodgkin Lymphoma / Hodgkin„É™„É≥„ÉëËÖ´
### Diffuse Large B-cell Lymphoma / „Å≥„Åæ„ÇìÊÄßÂ§ßÁ¥∞ËÉûÂûãBÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Follicular Lymphoma / ÊøæËÉûÊÄß„É™„É≥„ÉëËÖ´
### MALT Lymphoma / MALT„É™„É≥„ÉëËÖ´
### Mantle Cell Lymphoma / „Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´
### Burkitt lymphoma / Burkitt„É™„É≥„ÉëËÖ´
### Peripheral T-cell Lymphoma / Êú´Ê¢¢ÊÄßTÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Mycosis Fungoides and S√©zary Syndrome / ËèåÁä∂ÊÅØËÇâÁóá„ÉªS√©zaryÁóáÂÄôÁæ§

## Other Hematopoietic Tumors / „Åù„ÅÆ‰ªñ„ÅÆÈÄ†Ë°ÄÂô®ËÖ´Áòç

### Myelodysplastic Syndrome / È™®È´ÑÁï∞ÂΩ¢ÊàêÁóáÂÄôÁæ§
### Polycythemia Vera / ÁúüÊÄßËµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Essential Thrombocythemia / Êú¨ÊÖãÊÄßË°ÄÂ∞èÊùøË°ÄÁóá
### Primary Myelofibrosis / ÂéüÁô∫ÊÄßÈ™®È´ÑÁ∑öÁ∂≠Áóá
### Multiple Myeloma / Â§öÁô∫ÊÄßÈ™®È´ÑËÖ´
### MGUS / MGUS
### Waldenstr√∂m's Macroglobulinemia / ÂéüÁô∫ÊÄß„Éû„ÇØ„É≠„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Heavy-Chain Disease / HÈéñÁóÖ

## Other Blood Cell Disorder / „Åù„ÅÆ‰ªñ„ÅÆË°ÄÁêÉÁï∞Â∏∏

### Erythrocytosis / Ëµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Leukemoid Reaction / È°ûÁôΩË°ÄÁóÖÂèçÂøú
### Agranulocytosis / ÁÑ°È°ÜÁ≤íÁêÉÁóá
### Infectious Mononucleosis / ‰ºùÊüìÊÄßÂçòÊ†∏Áóá
### Langerhans Cell Histiocytosis / LangerhansÁ¥∞ËÉûÁµÑÁπîÁêÉÁóá
### Hemophagocytic Syndrome / Ë°ÄÁêÉË≤™È£üÁóáÂÄôÁæ§

## Hemostasis and Coagulation Disorder / Ê≠¢Ë°Ä„ÉªÂáùÂõ∫Á≥ª„ÅÆÁï∞Â∏∏

### Immune Thrombocytopenic Purpura / ÂÖçÁñ´ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Thrombotic Thrombocytopenic Purpura / Ë°ÄÊ†ìÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Hemolytic Uremic Syndrome / Ê∫∂Ë°ÄÊÄßÂ∞øÊØíÁóáÁóáÂÄôÁæ§
### Disseminated Intravascular Coagulation / Êí≠Á®ÆÊÄßË°ÄÁÆ°ÂÜÖÂáùÂõ∫
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá -->

# Rheumatology / „É™„Ç¶„Éû„ÉÅÁßë

<!-- ## Allergy / „Ç¢„É¨„É´„ÇÆ„Éº

### Anaphylaxis / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº
### Food Allergy / È£üÁâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Drug Allergy / Ëñ¨Áâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Serem Sickness / Ë°ÄÊ∏ÖÁóÖ

## Collagen Disease (Arthritis) / ËÜ†ÂéüÁóÖÔºàÈñ¢ÁØÄÁÇéÔºâ

### Rheumatoid Arthritis / Èñ¢ÁØÄ„É™„Ç¶„Éû„ÉÅ
### Juvenile Idiopathic Arthritis / Ëã•Âπ¥ÊÄßÁâπÁô∫ÊÄßÈñ¢ÁØÄÁÇé
### Adult Still's Disease / Êàê‰∫∫StillÁóÖ
### Ankylosing Spondylitis / Âº∑Áõ¥ÊÄßËÑäÊ§éÁÇé
### Psoriatic Arthritis / ‰πæÁô¨ÊÄßÈñ¢ÁØÄÁÇé
### Reactive Arthritis / ÂèçÂøúÊÄßÈñ¢ÁØÄÁÇé

## Collagen Disease (Systemic) / ËÜ†ÂéüÁóÖÔºàÂÖ®Ë∫´ÊÄßÔºâ

### Systemic Lupus Erythematosus / ÂÖ®Ë∫´ÊÄß„Ç®„É™„ÉÜ„Éû„Éà„Éº„Éá„Çπ
### Scleroderma / Âº∑ÁöÆÁóá
### Polymyositis and Dermatomyositis / Â§öÁô∫ÊÄßÁ≠ãÁÇé„ÉªÁöÆËÜöÁ≠ãÁÇé
### Mixed Connective Tissue Disease / Ê∑∑ÂêàÊÄßÁµêÂêàÁµÑÁπîÁóÖ
### Polymyalgia Rheumatica / „É™„Ç¶„Éû„ÉÅÊÄßÂ§öÁô∫Á≠ãÁóõÁóá
### Fibromyalgia / Á∑öÁ∂≠Á≠ãÁóõÁóá
### Sj√∂gren's Syndrome / Sj√∂grenÁóáÂÄôÁæ§
### Behcet's Disease / BehcetÁóÖ
### Rheumatic Fever / „É™„Ç¶„Éû„ÉÅÁÜ±
### Antiphospholipid Syndrome / Êäó„É™„É≥ËÑÇË≥™Êäó‰ΩìÁóáÂÄôÁæ§
### IgG4-Related Disease / IgG4Èñ¢ÈÄ£ÁñæÊÇ£
### Goodpasture Syndrome / GoodpastureÁóáÂÄôÁæ§
### Sarcoidosis / „Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

## Collagen Disease (Vasculitis) / ËÜ†ÂéüÁóÖÔºàË°ÄÁÆ°ÁÇéÔºâ

### Giant Cell Arteritis / Â∑®Á¥∞ËÉûÊÄßÂãïËÑàÁÇé
### Takayasu's Arteritis / È´òÂÆâÂãïËÑàÁÇé
### Polyarteritis Nodosa / ÁµêÁØÄÊÄßÂ§öÁô∫ÂãïËÑàÁÇé
### Kawasaki Disease / Â∑ùÂ¥éÁóÖ
### Microscopic Polyangiitis / È°ïÂæÆÈè°ÁöÑÂ§öÁô∫Ë°ÄÁÆ°ÁÇé
### Granulomatosis with Polyangiitis / Â§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### Eosinophilic Granulomatosis with Polyangiitis / Â•ΩÈÖ∏ÁêÉÊÄßÂ§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### IgA Vasculitis / IgAË°ÄÁÆ°ÁÇé -->

# Infectious Diseases / ÊÑüÊüìÁóáÁßë

<!-- 

## Gram-Positive Bacterial Infection / „Ç∞„É©„É†ÈôΩÊÄßËèåÊÑüÊüìÁóá

### Staphylococcus Aureus Infection / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Staphylococcus Epidermidis Infection / Ë°®ÁöÆ„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pyogenes Infection / ÂåñËÜø„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Agalactiae Infection / BÁæ§„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pneumoniae Infection / ËÇ∫ÁÇéÁêÉËèåÊÑüÊüìÁóá
### Viridans Streptococci Infection / Á∑ëËâ≤„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Enterococcus Infection / ËÖ∏ÁêÉËèåÊÑüÊüìÁóá
### Diphtheria / „Ç∏„Éï„ÉÜ„É™„Ç¢
### Listeriosis / „É™„Çπ„ÉÜ„É™„Ç¢Áóá
### Anthrax / ÁÇ≠ÁñΩ
### Botulism / „Éú„ÉÑ„É™„Éå„ÇπÁóá
### Tetanus / Á†¥ÂÇ∑È¢®
### Clostridium Perfringens Infection / „Ç¶„Çß„É´„Ç∑„É•ËèåÊÑüÊüìÁóá
### Clostridioides Difficile Infection / „Éá„Ç£„Éï„Ç£„Ç∑„É´ËèåÊÑüÊüìÁóá
### Non-Sporeforming Anaerobe Infection / ÁÑ°ËäΩËÉûÂ´åÊ∞óÊÄßËèåÊÑüÊüìÁóá

## Gram-Negative Bacterial Infection / „Ç∞„É©„É†Èô∞ÊÄßËèåÊÑüÊüìÁóá

### Escherichia Coli Infection / Â§ßËÖ∏ËèåÊÑüÊüìÁóá
### Shigellosis / Á¥∞ËèåÊÄßËµ§Áó¢
### Typhoid Fever / ËÖ∏„ÉÅ„Éï„Çπ
### Salmonellosis / „Çµ„É´„É¢„Éç„É©Áóá
### Plague / „Éö„Çπ„Éà
### Yersinia Enterocolitica Infection / „Ç®„É´„Ç∑„Éã„Ç¢ÊÑüÊüìÁóá
### Klebsiella Pneumoniae Infection / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ÊÑüÊüìÁóá
### Serratia Marcescens Infection / „Çª„É©„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Cholera / „Ç≥„É¨„É©
### Vibrio Parahaemolyticus Infection / ËÖ∏ÁÇé„Éì„Éñ„É™„Ç™ÊÑüÊüìÁóá
### Vibrio Vulnificus Infection / „Éê„É´„Éã„Éï„Ç£„Ç´„ÇπËèåÊÑüÊüìÁóá
### Campylobacter Jejuni Infection / „Ç´„É≥„Éî„É≠„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Helicobacter Pylori Infection / „Éî„É≠„É™ËèåÊÑüÊüìÁóá
### Haemophilus Influenzae Infection / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåÊÑüÊüìÁóá
### Pertussis / ÁôæÊó•Âí≥
### Pseudomonas Aeruginosa Infection / Á∑ëËÜøËèåÊÑüÊüìÁóá
### Acinetobacter Baumannii Infection / „Ç¢„Ç∑„Éç„Éà„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Legionellosis / „É¨„Ç∏„Ç™„Éç„É©Áóá
### Brucellosis / „Éñ„É´„Çª„É©Áóá
### Tularemia / ÈáéÂÖéÁóÖ
### Cat-Scratch Disease / „Å≠„Åì„Å≤„Å£„Åã„ÅçÁóÖ
### Neisseria Gonorrhoeae Infection / Ê∑ãËèåÊÑüÊüìÁóá
### Neisseria Meningitidis Infection / È´ÑËÜúÁÇéËèåÊÑüÊüìÁóá
### Moraxella Catarrhalis Infection / „É¢„É©„ÇØ„Çª„É©ÊÑüÊüìÁóá

## Other Bacterial Infection / „Åù„ÅÆ‰ªñ„ÅÆÁ¥∞ËèåÊÑüÊüìÁóá

### Actinomycosis / ÊîæÁ∑öËèåÁóá
### Nocardiosis / „Éé„Ç´„É´„Ç∏„Ç¢Áóá
### Tuberculosis / ÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Syphilis / Ê¢ÖÊØí
### Borreliosis / „Éú„É¨„É™„Ç¢Áóá
### Leptospirosis / „É¨„Éó„Éà„Çπ„Éî„É©Áóá
### Chlamydia Infection / „ÇØ„É©„Éü„Ç∏„Ç¢ÊÑüÊüìÁóá
### Mycoplasma Infection / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûÊÑüÊüìÁóá
### Rickettsia Infection / „É™„Ç±„ÉÉ„ÉÅ„Ç¢ÊÑüÊüìÁóá

## DNA Viral Infection / DNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Herpes Simplex Virus Infection / ÂçòÁ¥î„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Varicella-Zoster Virus Infection / Ê∞¥ÁóòÂ∏ØÁä∂Áñ±Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Epstein-Barr Virus Infection / EB„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Cytomegalovirus Infection / „Çµ„Ç§„Éà„É°„Ç¨„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Herpesvirus 6 & 7 Infection / „Éí„Éà„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Papillomavirus Infection / „Éí„Éà„Éë„Éî„É≠„Éº„Éû„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Poxvirus Infection / „Éù„ÉÉ„ÇØ„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Parvovirus Infection / „Éë„É´„Éú„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Adenovirus Infection / „Ç¢„Éá„Éé„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Hepatitis B / BÂûãËÇùÁÇé

## RNA Viral Infection / RNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Influenza / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂
### COVID-19 / Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### SARS / ÈáçÁóáÊÄ•ÊÄßÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### MERS / ‰∏≠Êù±ÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### Norovirus Infection / „Éé„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rotavirus Infection / „É≠„Çø„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Enterovirus Infection / „Ç®„É≥„ÉÜ„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Measles Virus Infection / È∫ªÁñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rubella Virus Infection / È¢®Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Mumps Virus Infection / „É†„É≥„Éó„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Japanese Encephalitis / Êó•Êú¨ËÑ≥ÁÇé
### West Nile Encephalitis / „Ç¶„Ç®„Çπ„Éà„Éä„Ç§„É´ËÑ≥ÁÇé
### Rabies / ÁãÇÁä¨ÁóÖ
### Dengue Fever / „Éá„É≥„Ç∞ÁÜ±
### Chikungunya Fever / „ÉÅ„ÇØ„É≥„Ç∞„Éã„Ç¢ÁÜ±
### Zika Fever / „Ç∏„Ç´ÁÜ±
### Ebola Hemorrhagic Fever / „Ç®„Éú„É©Âá∫Ë°ÄÁÜ±
### SFTS / ÈáçÁóáÁÜ±ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÁóáÂÄôÁæ§
### HIV Infection / HIVÊÑüÊüìÁóá
### HTLV-1 Infection / HTLV-1ÊÑüÊüìÁóá
### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé

## Fungal Infection / ÁúüËèåÊÑüÊüìÁóá

### Candidiasis / „Ç´„É≥„Ç∏„ÉÄÁóá
### Aspergillosis / „Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Mucormycosis / „É†„Éº„Ç≥„É´Áóá
### Cryptococcosis / „ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„ÇØ„ÇπÁóá
### Pneumocystis Infection / „Éã„É•„Éº„É¢„Ç∑„Çπ„ÉÅ„ÇπÊÑüÊüìÁóá
### Histoplasmosis / „Éí„Çπ„Éà„Éó„É©„Çπ„ÉûÁóá
### Coccidioidomycosis / „Ç≥„ÇØ„Ç∑„Ç∏„Ç™„Ç§„Éá„ÇπÁóá
### Blastomycosis / „Éñ„É©„Çπ„Éà„Éü„Çª„ÇπÁóá

## Protozoal Infection / ÂéüËô´ÊÑüÊüìÁóá

### Amebiasis / „Ç¢„É°„Éº„ÉêËµ§Áó¢
### Giardiasis / „É©„É≥„Éñ„É´Èû≠ÊØõËô´Áóá
### Cryptosporidiosis / „ÇØ„É™„Éó„Éà„Çπ„Éù„É™„Ç∏„Ç¶„É†Áóá
### Malaria / „Éû„É©„É™„Ç¢
### Babesiosis / „Éê„Éô„Ç∑„Ç¢Áóá
### Toxoplasmosis / „Éà„Ç≠„ÇΩ„Éó„É©„Ç∫„ÉûÁóá
### Leishmaniasis / „É™„Éº„Ç∑„É•„Éû„Éã„Ç¢Áóá
### African Sleeping Sickness / „Ç¢„Éï„É™„Ç´Áù°Áú†ÁóÖ
### Chagas Disease / „Ç∑„É£„Éº„Ç¨„ÇπÁóÖ
### Trichomoniasis / „Éà„É™„Ç≥„É¢„Éä„ÇπÁóá

## Helminthic Infection / Ë†ïËô´ÊÑüÊüìÁóá

### Ascariasis / ÂõûËô´Áóá
### Enterobiasis / ËüØËô´Áóá
### Trichuriasis / Èû≠Ëô´Áóá
### Hookworm Infection / Èâ§Ëô´Áóá
### Strongyloidiasis / Á≥ûÁ∑öËô´Áóá
### Anisakiasis / „Ç¢„Éã„Çµ„Ç≠„Çπ
### Filariasis / „Éï„Ç£„É©„É™„Ç¢Áóá
### Onchocerciasis / „Ç™„É≥„Ç≥„Çª„É´„Ç´Áóá
### Loiasis / „É≠„Ç¢Á≥∏Áä∂Ëô´Áóá
### Gnathostomiasis / È°éÂè£Ëô´Áóá
### Angiostrongyliasis / Â∫ÉÊù±‰ΩèË°ÄÁ∑öËô´Áóá
### Trichinellosis / ÊóãÊØõËô´Áóá
### Schistosomiasis / ‰ΩèË°ÄÂê∏Ëô´Áóá
### Clonorchiasis / ËÇùÂê∏Ëô´Áóá
### Metagonimiasis / Ê®™Â∑ùÂê∏Ëô´Áóá
### Paragonimiasis / ËÇ∫Âê∏Ëô´Áóá
### Diphyllobothriasis / Ë£ÇÈ†≠Êù°Ëô´Áóá
### Taeniasis Saginata / ÁÑ°Èâ§Êù°Ëô´Áóá
### Taeniasis Solium / ÊúâÈâ§Êù°Ëô´Áóá
### Echinococcosis / ÂåÖËô´Áóá

-->

# Neurology / Á•ûÁµåÁßë

<!-- ## Cerebral Infarction / ËÑ≥Ê¢óÂ°û

### Atherothrombotic Infarction / „Ç¢„ÉÜ„É≠„Éº„É†Ë°ÄÊ†ìÊÄßËÑ≥Ê¢óÂ°û
### Cardioembolic Infarction / ÂøÉÂéüÊÄßËÑ≥Â°ûÊ†ìÁóá
### Lacunar Infarction / „É©„ÇØ„ÉäÊ¢óÂ°û
### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú
### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá
### Cerebellar Infarction / Â∞èËÑ≥Ê¢óÂ°û
### Wallenberg Syndrome / WallenbergÁóáÂÄôÁæ§

## Cerebral Hemorrhage / ËÑ≥Âá∫Ë°Ä

### Putaminal Hemorrhage / Ë¢´ÊÆªÂá∫Ë°Ä
### Thalamic Hemorrhage / Ë¶ñÂ∫äÂá∫Ë°Ä
### Brainstem Hemorrhage / ËÑ≥ÂππÂá∫Ë°Ä
### Cerebellar Hemorrhage / Â∞èËÑ≥Âá∫Ë°Ä
### Subcortical Hemorrhage / ÁöÆË≥™‰∏ãÂá∫Ë°Ä
### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

## Other Cerebrovascular Disease / „Åù„ÅÆ‰ªñ„ÅÆËÑ≥Ë°ÄÁÆ°ÁñæÊÇ£

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§
### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢
### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ
### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑàÊµ∑Á∂øÈùôËÑàÊ¥ûÁòª
### Dural Arteriovenous Fistula / Á°¨ËÜúÂãïÈùôËÑàÁòª
### Sinus Thrombosis / ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá
### Hypertensive Encephalopathy / È´òË°ÄÂúßÊÄßËÑ≥Áóá
### Spinal Arteriovenous Malformation / ËÑäÈ´ÑÂãïÈùôËÑàÂ•áÂΩ¢
### Spinal Cord Infarction / ËÑäÈ´ÑÊ¢óÂ°û

## Dementia / Ë™çÁü•Áóá

### Alzheimer Type Dementia / AlzheimerÂûãË™çÁü•Áóá
### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá
### Dementia with Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá
### Frontotemporal Lobar Degeneration / ÂâçÈ†≠ÂÅ¥È†≠ËëâÂ§âÊÄßÁóá

## Neurodegenerative Disease / Á•ûÁµåÂ§âÊÄßÁñæÊÇ£

### Parkinson's Disease / ParkinsonÁóÖ
### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫
### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá
### Huntington's Disease / HuntingtonÁóÖ
### MSA-C / MSA-C
### MSA-P / MSA-P
### Shy-Drager Syndrome / Shy-DragerÁóáÂÄôÁæ§
### Cortical Cerebellar Atrophy / ÁöÆË≥™ÊÄßÂ∞èËÑ≥ËêéÁ∏ÆÁóá
### SCA-3 / SCA-3
### SCA-6 / SCA-6
### Dentato-Rubro-Pallido-Luysian Atrophy / Ê≠ØÁä∂Ê†∏Ëµ§Ê†∏Ê∑°ËíºÁêÉ„É´„Ç§‰ΩìËêéÁ∏ÆÁóá
### Friedreich Ataxia / FriedreichÈÅãÂãïÂ§±Ë™øÁóá
### Syringomyelia / ËÑäÈ´ÑÁ©∫Ê¥ûÁóá
### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßÈÄ£ÂêàÊÄßËÑäÈ´ÑÂ§âÊÄßÁóá
### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá
### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá
### Spinal and Bulbar Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

## Demyelinating Disease / ËÑ±È´ÑÊÄßÁñæÊÇ£

### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá
### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé
### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé
### Adrenoleukodystrophy / ÂâØËÖéÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Metachromatic Leukodystrophy / Áï∞ÊüìÊÄßÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

## Peripheral Neuropathy / Êú´Ê¢¢Á•ûÁµåÈöúÂÆ≥

### Guillain-Barr√© Syndrome / Guillain-Barr√©ÁóáÂÄôÁæ§
### Chronic Inflammatory Demyelinating Polyneuropathy / ÊÖ¢ÊÄßÁÇéÁóáÊÄßËÑ±È´ÑÊÄßÂ§öÁô∫Á•ûÁµåÁÇé
### Charcot-Marie-Tooth Disease / Charcot-Marie-ToothÁóÖ
### Familial Amyloid Polyneuropathy / ÂÆ∂ÊóèÊÄß„Ç¢„Éü„É≠„Ç§„Éâ„Éù„É™„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº
### Diabetic Neuropathy / Á≥ñÂ∞øÁóÖÊÄßÁ•ûÁµåÈöúÂÆ≥
### Wernicke Encephalopathy / WernickeËÑ≥Áóá
### Carcinomatous Neuropathy / ÁôåÊÄß„Éã„É•„É≠„Éë„ÉÅ„Éº
### Crow-Fukase Syndrome / Crow-FukaseÁóáÂÄôÁæ§
### Trigeminal Neuralgia / ‰∏âÂèâÁ•ûÁµåÁóõ
### Bell's Palsy / BellÈ∫ªÁó∫
### Ramsay Hunt Syndrome / Ramsay HuntÁóáÂÄôÁæ§

## Muscular Disease / Á≠ãÁñæÊÇ£

### Duchenne Muscular Dystrophy / DuchenneÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Becker Muscular Dystrophy / BeckerÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Limb-Girdle Muscular Dystrophy / LGÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Fascioscapulohumeral Muscular Dystrophy / FSHÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Congenital Muscular Dystrophy / ÂÖàÂ§©ÊÄßÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Myotonic Dystrophy / Á≠ãÂº∑Áõ¥ÊÄß„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Mitochondrial Encephalomyopathy / „Éü„Éà„Ç≥„É≥„Éâ„É™„Ç¢ËÑ≥Á≠ãÁóá
### Periodic Paralysis / Âë®ÊúüÊÄßÂõõËÇ¢È∫ªÁó∫
### Myasthenia Gravis / ÈáçÁóáÁ≠ãÁÑ°ÂäõÁóá
### Lambert-Eaton Myasthenic Syndrome / Lambert-EatonÁóáÂÄôÁæ§

## Phacomatosis / ÊØçÊñëÁóá

### Neurofibromatosis Type 1 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºëÂûã
### Neurofibromatosis Type 2 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºíÂûã
### Tuberous Sclerosis / ÁµêÁØÄÊÄßÁ°¨ÂåñÁóá
### Von Hippel-Lindau Disease / Von Hippel-LindauÁóÖ
### Sturge-Weber Syndrome / Sturge-WeberÁóáÂÄôÁæ§

## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Bacterial Meningitis / Á¥∞ËèåÊÄßÈ´ÑËÜúÁÇé
### Tuberculous Meningitis / ÁµêÊ†∏ÊÄßÈ´ÑËÜúÁÇé
### Fungal Meningitis / ÁúüËèåÊÄßÈ´ÑËÜúÁÇé
### Viral Meningitis / „Ç¶„Ç§„É´„ÇπÊÄßÈ´ÑËÜúÁÇé
### Herpes Simplex Encephalitis / ÂçòÁ¥î„Éò„É´„Éö„ÇπËÑ≥ÁÇéÁóá
### HIV-Associated Neurocognitive Disorder / HIV Èñ¢ÈÄ£Á•ûÁµåË™çÁü•ÈöúÂÆ≥
### HTLV-1 Associated Myelopathy / HTLV-1 Èñ¢ÈÄ£ËÑäÈ´ÑÁóá
### Subacute Sclerosing Panencephalitis / ‰∫úÊÄ•ÊÄßÁ°¨ÂåñÊÄßÂÖ®ËÑ≥ÁÇé
### Progressive Multifocal Leukoencephalopathy / ÈÄ≤Ë°åÊÄßÂ§öÂ∑£ÊÄßÁôΩË≥™ËÑ≥Áóá
### Creutzfeldt-Jakob Disease / Creutzfeldt-JakobÁóÖ
### Brain Abscess / ËÑ≥ËÜøÁòç
### Neurosyphilis / Á•ûÁµåÊ¢ÖÊØí
### Acute Encephalopathy / ÊÄ•ÊÄßËÑ≥Áóá
### Reye Syndrome / ReyeÁóáÂÄôÁæ§
### Acute Cerebellar Ataxia / ÊÄ•ÊÄßÂ∞èËÑ≥Â§±Ë™øÁóá

## Brain Tumor / ËÑ≥ËÖ´Áòç

### Diffuse Astrocytoma / „Å≥„Åæ„ÇìÊÄßÊòüÁ¥∞ËÉûËÖ´
### Glioblastoma / ËÜ†ËäΩËÖ´
### Oligodendroglioma / ‰πèÁ™ÅËµ∑ËÜ†ËÖ´
### Ependymoma / ‰∏äË°£ËÖ´
### Medulloblastoma / È´ÑËäΩËÖ´
### Meningioma / È´ÑËÜúËÖ´
### Schwannoma / Á•ûÁµåÈûòËÖ´
### Pituitary Adenoma / ‰∏ãÂûÇ‰ΩìËÖ∫ËÖ´
### Craniopharyngioma / È†≠ËìãÂíΩÈ†≠ËÖ´
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç
### Hemangioblastoma / Ë°ÄÁÆ°ËäΩËÖ´
### Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Metastatic Brain Tumor / Ëª¢ÁßªÊÄßËÑ≥ËÖ´Áòç
### Spinal Cord Tumor / ËÑäÈ´ÑËÖ´Áòç

## Functional Disease / Ê©üËÉΩÊÄßÁñæÊÇ£

### Rolandic Epilepsy / Roland„Å¶„Çì„Åã„Çì
### Temporal Lobe Epilepsy / ÂÅ¥È†≠Ëëâ„Å¶„Çì„Åã„Çì
### Childhood Absence Epilepsy / Â∞èÂÖêÊ¨†Á•û„Å¶„Çì„Åã„Çì
### Juvenile Myoclonic Epilepsy / Ëã•Âπ¥„Éü„Ç™„ÇØ„É≠„Éã„Éº„Å¶„Çì„Åã„Çì
### West Syndrome / WestÁóáÂÄôÁæ§
### Lennox-Gastaut Syndrome / Lennox-GastautÁóáÂÄôÁæ§
### Dravet Syndrome / DravetÁóáÂÄôÁæ§
### Febrile Seizure / ÁÜ±ÊÄß„Åë„ÅÑ„Çå„Çì
### Cerebral Palsy / ËÑ≥ÊÄßÈ∫ªÁó∫
### Migraine / ÁâáÈ†≠Áóõ
### Tension-Type Headache / Á∑äÂºµÊÄßÈ†≠Áóõ
### Cluster Headache / Áæ§Áô∫È†≠Áóõ
### Restless Legs Syndrome / „ÇÄ„Åö„ÇÄ„ÅöËÑöÁóáÂÄôÁæ§

## Head Injury / È†≠ÈÉ®Â§ñÂÇ∑

### Skull Base Fracture / È†≠ËìãÂ∫ïÈ™®Êäò
### Cranial Vault Fracture / ÂÜÜËìãÈÉ®È™®Êäò
### Acute Epidural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜúÂ§ñË°ÄËÖ´
### Acute Subdural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Chronic Subdural Hematoma / ÊÖ¢ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Cerebral Contusion / ËÑ≥Êå´ÂÇ∑
### Diffuse Axonal Injury / „Å≥„Åæ„ÇìÊÄßËª∏Á¥¢ÊêçÂÇ∑
### Spinal Cord Injury / ËÑäÈ´ÑÊêçÂÇ∑
### Normal Pressure Hydrocephalus / Ê≠£Â∏∏ÂúßÊ∞¥È†≠Áóá -->

# Psychiatry / Á≤æÁ•ûÁßë

# Ophthalmology / ÁúºÁßë

# Otolaryngology / ËÄ≥ÈºªÂíΩÂñâÁßë

# Dermatology / ÁöÆËÜöÁßë

<!-- ## Eczema and Dermatitis / ÊπøÁñπ„ÉªÁöÆËÜöÁÇé

### Contact Dermatitis /  Êé•Ëß¶ÁöÆËÜöÁÇé
### Atopic Dermatitis / „Ç¢„Éà„Éî„ÉºÊÄßÁöÆËÜöÁÇé
### Asteatotic Eczema / ÁöÆËÑÇÊ¨†‰πèÊÄßÊπøÁñπ
### Seborrheic Dermatitis / ËÑÇÊºèÊÄßÁöÆËÜöÁÇé
### Nummular Eczema / Ë≤®Âπ£Áä∂ÊπøÁñπ
### Autosensitization Dermatitis / Ëá™ÂÆ∂ÊÑü‰ΩúÊÄßÁöÆËÜöÁÇé
### Stasis Dermatitis / „ÅÜ„Å£ÊªûÊÄßÁöÆËÜöÁÇé
### Lichen Vidal / VidalËãîÁô¨
### Pompholyx / Ê±óÁñ±

## Urticaria and Pruritis / ËïÅÈ∫ªÁñπ„ÉªÊéªÁóí

### Urticaria / ËïÅÈ∫ªÁñπ
### Angioedema / Ë°ÄÁÆ°ÊÄßÊµÆËÖ´
### Prurigo / ÁóíÁñπ
### Pruritus Cutaneous / ÁöÆËÜöÁòôÁóíÁóá

## Erythema and Drug Eruption / Á¥ÖÊñëÁóá„ÉªËñ¨Áñπ

### Erythema Exsudativum Multiforme / Â§öÂΩ¢Êª≤Âá∫ÊÄßÁ¥ÖÊñë
### Erythema Nodosum / ÁµêÁØÄÊÄßÁ¥ÖÊñë
### Erythema Induratum / Á°¨ÁµêÊÄßÁ¥ÖÊñë
### Sweet's Disease / SweetÁóÖ
### Drug Eruption / Ëñ¨Áñπ
### Fixed Drug Eruption / Âõ∫ÂÆöËñ¨Áñπ
### Stevens-Johnson Syndrome / Stevens-JohnsonÁóáÂÄôÁæ§
### Toxic Epidermal Necrolysis / ‰∏≠ÊØíÊÄßË°®ÁöÆÂ£äÊ≠ªÁóá
### Drug-Induced Hypersensitivity Syndrome / Ëñ¨Ââ§ÊÄßÈÅéÊïèÁóáÁóáÂÄôÁæ§
### Skin Disorders Caused by Anticancer Drugs / Êäó„Åå„ÇìËñ¨„Å´„Çà„ÇãÁöÆËÜöÈöúÂÆ≥
### Erythroderma / Á¥ÖÁöÆÁóá
### Graft-Versus-Host Disease / ÁßªÊ§çÁâáÂØæÂÆø‰∏ªÁóÖ

## Bullous Dermatoses and Pustulosis / Ê∞¥Áñ±Áóá„ÉªËÜøÁñ±Áóá

### Pemphigus Vulgaris / Â∞ãÂ∏∏ÊÄßÂ§©Áñ±Áò°
### Pemphigus Foliaceus / ËêΩËëâÁä∂Â§©Áñ±Áò°
### Bullous Pemphigoid / Ê∞¥Áñ±ÊÄßÈ°ûÂ§©Áñ±Áò°
### Dermatitis Herpetiformis Duhring / DuhringÁñ±ÁñπÁä∂ÁöÆËÜöÁÇé
### Epidermolysis Bullosa Acquisita / ÂæåÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Epidermolysis Bullosa Hereditaria / ÂÖàÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Palmoplantar Pustulosis / ÊéåËπ†ËÜøÁñ±Áóá

## Keratosis / ËßíÂåñÁóá

### Psoriasis Vulgaris / Â∞ãÂ∏∏ÊÄß‰πæÁô¨
### Guttate Psoriasis / Êª¥Áä∂‰πæÁô¨
### Pustular Psoriasis / ËÜøÁñ±ÊÄß‰πæÁô¨
### Psoriatic Erythroderma / ‰πæÁô¨ÊÄßÁ¥ÖÁöÆÁóá
### Parapsoriasis En Plaques / Â±ÄÈù¢Áä∂È°û‰πæÁô¨
### Pityriasis Lichenoides / ËãîÁô¨Áä∂Á≤ÉÁ≥†Áñπ
### Lichen Planus / ÊâÅÂπ≥ËãîÁô¨
### Pityriasis Rosea Gibert / Gibert„Å∞„ÇâËâ≤Á≤ÉÁ≥†Áñπ
### Pityriasis Rubra Pilaris / ÊØõÂ≠îÊÄßÁ¥ÖËâ≤Á≤ÉÁ≥†Áñπ
### Keratosis Pilaris / ÊØõÂ≠îÊÄßËßíÂåñÁóá
### Clavus and Callus / È∂èÁúº„ÉªËÉºËÉù
### Acanthosis Nigricans / ÈªíËâ≤Ë°®ÁöÆËÖ´
### Ichthyosis Vulgaris / Â∞ãÂ∏∏ÊÄßÈ≠öÈ±óÁô¨
### X-Linked Ichthyosis / XÈÄ£ÈéñÊÄßÈ≠öÈ±óÁô¨
### Congenital Ichthyosiform Erythroderma / ÂÖàÂ§©ÊÄßÈ≠öÈ±óÁô¨ÊßòÁ¥ÖÁöÆÁóá
### Epidermolytic Ichthyosis / Ë°®ÁöÆËûçËß£ÊÄßÈ≠öÈ±óÁô¨
### Palmoplantar Keratoderma / ÊéåËπ†ËßíÂåñÁóá
### Darier's Disease / DarierÁóÖ

## Pigmentary Disorder / Ëâ≤Á¥†Áï∞Â∏∏Áóá

### Oculocutaneous Albinism / ÁúºÁöÆËÜöÁôΩÁöÆÁóá
### Vitiligo Vulgaris / Â∞ãÂ∏∏ÊÄßÁôΩÊñë
### Nevus Depigmentosus / ËÑ±Ëâ≤Á¥†ÊÄßÊØçÊñë
### Vogt-Koyanagi-Harada Disease / Vogt-Â∞èÊü≥-ÂéüÁî∞ÁóÖ
### Leucoderma Sutton / SuttonÁôΩÊñë
### Ephelides / ÈõÄÂçµÊñë
### Melasma / ËÇùÊñë
### Senile Lentigo / ËÄÅ‰∫∫ÊÄßËâ≤Á¥†Êñë

## Nevus / ÊØçÊñë

### Epidermal Nevus / Ë°®ÁöÆÊØçÊñë
### Sebaceous Nevus / ËÑÇËÖ∫ÊØçÊñë
### Melanocytic Nevus / Ëâ≤Á¥†ÊÄßÊØçÊñë
### Spitz Nevus / SpitzÊØçÊñë
### Nevus Spilus / ÊâÅÂπ≥ÊØçÊñë
### Nevus of Ota / Â§™Áî∞ÊØçÊñë
### Mongolian Spot / ËíôÂè§Êñë
### Blue Nevus / ÈùíËâ≤ÊØçÊñë

## Skin Tumor / ÁöÆËÜöËÖ´Áòç

### Seborrheic Keratosis / ËÑÇÊºèÊÄßËßíÂåñÁóá
### Porokeratosis / Ê±óÂ≠îËßíÂåñÁóá
### Epidermal Cyst / Ë°®ÁöÆÂö¢ËÖ´
### Hypertrophic Scar and Keloid / ËÇ•ÂéöÊÄßÁò¢Áóï„Éª„Ç±„É≠„Ç§„Éâ
### Mastocytoma / ËÇ•Ê∫ÄÁ¥∞ËÉûÁóá
### Infantile Hamangioma / ‰π≥ÂÖêË°ÄÁÆ°ËÖ´
### Glomus Tumor / „Ç∞„É≠„É†„ÇπËÖ´Áòç
### Kasabach-Merritt Syndrome / Kasabach-MerrittÁóáÂÄôÁæ§
### Capillary Malformation / ÊØõÁ¥∞Ë°ÄÁÆ°Â•áÂΩ¢
### Basal Cell Carcinoma / Âü∫Â∫ïÁ¥∞ËÉûÁôå
### Squamous Cell Carcinoma / ÊúâÊ£òÁ¥∞ËÉûÁôå
### Keratoacanthoma / „Ç±„É©„Éà„Ç¢„Ç´„É≥„Éà„Éº„Éû
### Solar Keratosis / Êó•ÂÖâËßíÂåñÁóá
### Bowen's Disease / BowenÁóÖ
### Extramammary Paget's Disease / ‰π≥ÊàøÂ§ñPagetÁóÖ
### Merkel Cell Carcinoma / MerkelÁ¥∞ËÉûÁôå
### Malignant Melanoma / ÊÇ™ÊÄßÈªíËâ≤ËÖ´
### Angiosarcoma / Ë°ÄÁÆ°ËÇâËÖ´
### Kaposi's Sarcoma / KaposiËÇâËÖ´
### Mycosis Fungoides / ËèåÁä∂ÊÅØËÇâÁóá
### S√©zary Syndrome / S√©zaryÁóáÂÄôÁæ§

## Skin Infection / ÁöÆËÜöÊÑüÊüìÁóá

### Folliculitis / ÊØõÂåÖÁÇé
### Furuncle and Carbuncle / Áô§„ÉªÁô∞
### Paronychia / Áà™Âõ≤ÁÇé
### Erysipelas / ‰∏πÊØí
### Cellulitis / ËúÇÂ∑£ÁÇé
### Necrotizing Fasciitis / Â£äÊ≠ªÊÄßÁ≠ãËÜúÁÇé
### Gas Gangrene / „Ç¨„ÇπÂ£äÁñΩ
### Impetigo Contagiosa / ‰ºùÊüìÊÄßËÜøÁóÇÁñπ
### Staphylococcal Scalded Skin Syndrome / „Éñ„Éâ„Ç¶ÁêÉËèåÊÄßÁÜ±ÂÇ∑ÊßòÁöÆËÜöÁóáÂÄôÁæ§
### Toxic Shock Syndrome / „Éà„Ç≠„Ç∑„ÉÉ„ÇØ„Ç∑„Éß„ÉÉ„ÇØÁóáÂÄôÁæ§
### Scarlet Fever / Áå©Á¥ÖÁÜ±
### Tuberculosis Cutis / ÁöÆËÜöÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Herpes Simplex / ÂçòÁ¥îÁñ±Áñπ
### Varicella / Ê∞¥Áóò
### Herpes Zoster / Â∏ØÁä∂Áñ±Áñπ
### Hand Foot and Mouth Disease / ÊâãË∂≥Âè£ÁóÖ
### Measles / È∫ªÁñπ
### Rubella / È¢®Áñπ
### Exanthema Subitum / Á™ÅÁô∫ÊÄßÁô∫Áñπ
### Erythema Infectiosum / ‰ºùÊüìÊÄßÁ¥ÖÊñë
### Gianotti Disease / GianottiÁóÖ
### Verruca Vulgaris / Â∞ãÂ∏∏ÊÄßÁñ£Ë¥Ö
### Verruca Plana / ÊâÅÂπ≥Áñ£Ë¥Ö
### Molluscum Contagiosum / ‰ºùÊüìÊÄßËªüÂ±ûËÖ´
### Dermatophytosis / ÁôΩÁô¨
### Cutaneous Candidiasis / ÁöÆËÜö„Ç´„É≥„Ç∏„ÉÄÁóá
### Malassezia Infection / „Éû„É©„Çª„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Sporotrichosis / „Çπ„Éù„É≠„Éà„É™„Ç≥„Éº„Ç∑„Çπ
### Dematiaceous Fungal Infection / ÈªíËâ≤ÁúüËèåÁóá
### Scabies / Áñ•Áô¨
### Pediculosis / „Ç∑„É©„ÉüÁóá
### Lyme Disease / „É©„Ç§„É†ÁóÖ
### Scrub Typhus / „ÉÑ„ÉÑ„Ç¨„É†„Ç∑ÁóÖ 

## Epidermal Appendage Disease / ÁöÆËÜöÈôÑÂ±ûÂô®„ÅÆÁñæÊÇ£

### Miliaria / Ê±óÁñπ
### Hyperhidrosis / Â§öÊ±óÁóá
### Anhidrosis / ÁÑ°Ê±óÁóá
### Bromidrosis / Ëá≠Ê±óÁóá
### Acne Valgaris / Â∞ãÂ∏∏ÊÄßÁó§Áò°
### Acneiform Eruption / Áó§Áò°ÊßòÁô∫Áñπ
### Rosacea / ÈÖíÁö∂
### Rosacea-Like Dermatitis / ÈÖíÁö∂ÊßòÁöÆËÜöÁÇé
### Androgenetic Alopecia / Áî∑ÊÄßÂûãËÑ±ÊØõÁóá
### Alopecia Areata / ÂÜÜÂΩ¢ËÑ±ÊØõÁóá
### Trichotillomania / ÊäúÊØõÁóá
### Ingrown Nail / Èô•ÂÖ•Áà™
-->

# Orthopedic Surgery / Êï¥ÂΩ¢Â§ñÁßë

# Urology / Ê≥åÂ∞øÂô®Áßë

<!-- ## Urinary Tract Dysfunction / Â∞øË∑ØÊ©üËÉΩÈöúÂÆ≥

### Hydronephrosis / Ê∞¥ËÖéÁóá
### Neurogenic Bladder / Á•ûÁµåÂõ†ÊÄßËÜÄËÉ±
### Overactive Bladder / ÈÅéÊ¥ªÂãïËÜÄËÉ±
### Stress Incontinence / ËÖπÂúßÊÄßÂ∞øÂ§±Á¶Å

## Urinary Tract and Genital Infection / Â∞øË∑Ø„ÉªÊÄßÂô®ÊÑüÊüìÁóá

### Pyelonephritis / ËÖéÁõÇËÖéÁÇé
### Renal Abscess / ËÖéËÜøÁòç
### Cystitis / ËÜÄËÉ±ÁÇé
### Urinary Tuberculosis / Â∞øË∑ØÁµêÊ†∏
### Urethritis / Â∞øÈÅìÁÇé
### Prostatitis / ÂâçÁ´ãËÖ∫ÁÇé
### Epididymitis / Á≤æÂ∑£‰∏ä‰ΩìÁÇé
### Orchitis / Á≤æÂ∑£ÁÇé

## Urinary Tract and Genital Tumor / Â∞øË∑Ø„ÉªÊÄßÂô®ËÖ´Áòç

### Urinary Stone / Â∞øË∑ØÁµêÁü≥
### Renal Cell Carcinoma / ËÖéÁ¥∞ËÉûÁôå
### Renal Pelvic and Ureteral Cancer / ËÖéÁõÇ„ÉªÂ∞øÁÆ°Áôå
### Bladder Cancer / ËÜÄËÉ±Áôå
### Penile Cancer / Èô∞ËåéÁôå
### Benign Prostatic Hyperplasia / ÂâçÁ´ãËÖ∫ËÇ•Â§ßÁóá
### Prostatic Cancer / ÂâçÁ´ãËÖ∫Áôå
### Testicular Tumor / Á≤æÂ∑£ËÖ´Áòç

## Genital Dysfunction / ÊÄßÂô®Ê©üËÉΩÁï∞Â∏∏
### Varicocele / Á≤æÁ¥¢ÈùôËÑàÁò§
### Testicular Torsion / Á≤æÂ∑£ÊçªËª¢Áóá
### Phimosis / ÂåÖËåé
### Erectile Dysfunction / ÂãÉËµ∑ÈöúÂÆ≥
### Priapism / ÊåÅÁ∂öÂãÉËµ∑Áóá
### Male Infertility / Áî∑ÊÄß‰∏çÂ¶äÁóá -->

# Gynecology / Â©¶‰∫∫Áßë


<!-- 

### Syphilis / Ê¢ÖÊØí
### Chancroid / ËªüÊÄß‰∏ãÁñ≥ 

-->

# Obstetrics / Áî£Áßë

# Pediatrics / Â∞èÂÖêÁßë

<!-- ## Cardiovascular Disease / Âæ™Áí∞Âô®ÁñæÊÇ£

### Atrial Septal Defect / ÂøÉÊàø‰∏≠ÈöîÊ¨†ÊêçÁóá
### Ventricular Septal Defect / ÂøÉÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Atrioventricular Septal Defect / ÊàøÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Patent Ductus Arteriosus / ÂãïËÑàÁÆ°ÈñãÂ≠òÁóá
### Coarctation of the Aorta / Â§ßÂãïËÑàÁ∏ÆÁ™ÑÁóá
### Eisenmenger Syndrome / EisenmengerÁóáÂÄôÁæ§
### Tetralogy of Fallot / FallotÂõõÂæ¥Áóá
### Complete Transposition of Great Arteries / ÂÆåÂÖ®Â§ßË°ÄÁÆ°Ëª¢‰ΩçÁóá
### Total Anomalous Pulmonary Venous Return / Á∑èËÇ∫ÈùôËÑàÈÇÑÊµÅÁï∞Â∏∏Áóá
### Double Outlet Right Ventricle / ‰∏°Â§ßË°ÄÁÆ°Âè≥ÂÆ§Ëµ∑ÂßãÁóá
### Hypoplastic Left Heart Syndrome / Â∑¶ÂøÉ‰ΩéÂΩ¢ÊàêÁóáÂÄôÁæ§
### Pulmonary Stenosis / ËÇ∫ÂãïËÑàÁã≠Á™ÑÁóá
### Pure Pulmonary Atresia / Á¥îÂûãËÇ∫ÂãïËÑàÈñâÈéñ
### Truncus Arteriosus Communis / Á∑èÂãïËÑàÂππÁóá
### Ruptured Aneurysm of the sinus of Valsalva / ValsalvaÊ¥ûÂãïËÑàÁò§Á†¥Ë£Ç
### Tricuspid Atresia / ‰∏âÂ∞ñÂºÅÈñâÈéñÁóá
### Ebstein's Disease / EbsteinÁóÖ
### Single Ventricle / ÂçòÂøÉÂÆ§Áóá

## Gastrointestinal Disease / Ê∂àÂåñÂô®ÁñæÊÇ£

### Congenital Esophageal Atresia / ÂÖàÂ§©ÊÄßÈ£üÈÅìÈñâÈéñ
### Hypertrophic Pyloric Stenosis / ËÇ•ÂéöÊÄßÂπΩÈñÄÁã≠Á™ÑÁóá
### Congenital Duodenal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂçÅ‰∫åÊåáËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Congenital Intestinal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂ∞èËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Intestinal Malrotation / ËÖ∏ÂõûËª¢Áï∞Â∏∏Áóá
### Meckel Diverticulum / MeckelÊÜ©ÂÆ§
### Intussusception / ËÖ∏ÈáçÁ©çÁóá
### Hirschsprung Disease / HirschsprungÁóÖ
### Necrotizing Enterocolitis / Â£äÊ≠ªÊÄßËÖ∏ÁÇé
### Anal Atresia / ÈéñËÇõ 
### Bochdalek Hernia / BochdalekÂ≠î„Éò„É´„Éã„Ç¢
### Omphalocele / ËáçÂ∏Ø„Éò„É´„Éã„Ç¢
### Gastroschisis / ËÖπÂ£ÅÁ†¥Ë£Ç
### Gilbert Syndrome / GilbertÁóáÂÄôÁæ§
### Crigler-Najjar Syndrome / Cirgler-NajjarÁóáÂÄôÁæ§
### Dubin-Johnson Syndrome / Dubin-JohnsonÁóáÂÄôÁæ§
### Rotor Syndrome / RotorÁóáÂÄôÁæ§
### Biliary Atresia / ËÉÜÈÅìÈñâÈéñÁóá
### Congenital Biliary Dilatation / ÂÖàÂ§©ÊÄßËÉÜÈÅìÊã°ÂºµÁóá

## Metabolism Disease / ‰ª£Ë¨ùÁñæÊÇ£

### Phenylketonuria / „Éï„Çß„Éã„É´„Ç±„Éà„É≥Â∞øÁóá
### Maple Syrup Urine Disease / „É°„Éº„Éó„É´„Ç∑„É≠„ÉÉ„ÉóÂ∞øÁóá
### Homocystinurea / „Éõ„É¢„Ç∑„Çπ„ÉÅ„É≥Â∞øÁóá
### Urea Cycle Defect / Â∞øÁ¥†„Çµ„Ç§„ÇØ„É´Áï∞Â∏∏Áóá
### Von Gierke Disease / Von GierkeÁóÖ
### Pompe Disease / PompeÁóÖ
### Galactosemia / „Ç¨„É©„ÇØ„Éà„Éº„ÇπË°ÄÁóá
### Lactose Intolerance / ‰π≥Á≥ñ‰∏çËÄêÁóá
### Mucopolysaccharidoses / „É†„Ç≥Â§öÁ≥ñÁóá
### Tay-Sachs Disease / Tay-SachsÁóÖ
### Fabry Disease / FabryÁóÖ
### Gaucher Disease / GaucherÁóÖ
### Nieman-Pick Disease / Nieman-PickÁóÖ
### Lesch-Nyhan Syndrome / Lesch-NyhanÁóáÂÄôÁæ§
### Wilson's Disease / WilsonÁóÖ
### Menkes Disease / MenkesÁóÖ
### Marfan Syndrome / MarfanÁóáÂÄôÁæ§
### Ehlers-Danlos Syndrome / Ehlers-DanlosÁóáÂÄôÁæ§
### Ketotic Hypoglycemia / „Ç±„Éà„É≥ÊÄß‰ΩéË°ÄÁ≥ñÁóá
### Acetonic Vomiting / „Ç¢„Çª„Éà„É≥Ë°ÄÊÄßÂòîÂêêÁóá
### Osteomalacia / È™®ËªüÂåñÁóá
### Osteogenesis Imperfecta / È™®ÂΩ¢Êàê‰∏çÂÖ®Áóá
### Chondrodysplasia / ËªüÈ™®Áï∞ÂΩ¢ÊàêÁóá

## Endocrine Disease / ÂÜÖÂàÜÊ≥åÁñæÊÇ£

### Growth Hormone Deficiency / ÊàêÈï∑„Éõ„É´„É¢„É≥Ê¨†‰πèÁóá
### Congenital Hypothyroidism / ÂÖàÂ§©ÊÄßÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Precocious Puberty / Êó©Áô∫ÊÄßÊÄùÊò•Êúü
### McCune-Albright Syndrome / McCune-AlbrightÁóáÂÄôÁæ§
### Turner Syndrome / TurnerÁóáÂÄôÁæ§
### Klinefelter Syndrome / KlinefelterÁóáÂÄôÁæ§
### Kallman Syndrome / KallmanÁóáÂÄôÁæ§
### Prader-Willi Syndrome / Prader-WilliÁóáÂÄôÁæ§
### Congenital Adrenocortical Hyperplasia / ÂÖàÂ§©ÊÄßÂâØËÖéÁöÆË≥™ÈÅéÂΩ¢Êàê
### Androgen Insensitivity Syndrome / „Ç¢„É≥„Éâ„É≠„Ç≤„É≥‰∏çÂøúÁóá

## Renal and Urologic Disease / ËÖé„ÉªÊ≥åÂ∞øÂô®ÁñæÊÇ£

### Polycystic Kidney Disease / Â§öÁô∫ÊÄßÂö¢ËÉûËÖé
### Sponge Kidney / Êµ∑Á∂øËÖé
### Horseshoe Kidney / È¶¨ËπÑËÖé
### Congenital Hydronephrosis / ÂÖàÂ§©ÊÄßÊ∞¥ËÖéÁóá
### Duplicated Renal Pelvis and Ureter / ÈáçË§áËÖéÂ≠üÂ∞øÁÆ°
### Ectopic Ureter / Â∞øÁÆ°Áï∞ÊâÄÈñãÂè£
### Ureterocele / Â∞øÁÆ°Áò§
### Vesicourethral Reflux / ËÜÄËÉ±Â∞øÁÆ°ÈÄÜÊµÅ
### Hypospadias / Â∞øÈÅì‰∏ãË£Ç
### Cryptorchidism / ÂÅúÁïôÁ≤æÂ∑£
### Hydrocele Testis / Èô∞Âö¢Ê∞¥ËÖ´

## Hematologic Disease / Ë°ÄÊ∂≤ÁñæÊÇ£

### Hemophilia / Ë°ÄÂèãÁóÖ
### Von Willebrand Disease / Von WillebrandÁóÖ
### Bernard-Soulier Syndrome / Bernard-SoulierÁóáÂÄôÁæ§
### Glanzmann Thrombasthenia / Ë°ÄÂ∞èÊùøÁÑ°ÂäõÁóá

## Immune Disease / ÂÖçÁñ´ÁñæÊÇ£

### Severe Combined Immunodeficiency / ÈáçÁóáË§áÂêàÂÖçÁñ´‰∏çÂÖ®Áóá
### X-linked Agammaglobulinemia / XÈÄ£ÈéñÁÑ°Œ≥-„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Hyper-IgM Syndrome / È´òIgMÁóáÂÄôÁæ§
### Wiskott-Aldrich Syndrome / Wiskott-AldrichÁóáÂÄôÁæ§
### Ataxia Telangiectasia / ÊØõÁ¥∞Ë°ÄÁÆ°Êã°ÂºµÊÄßÈÅãÂãïÂ§±Ë™øÁóá
### DiGeorge Syndrome / DiGeorgeÁóáÂÄôÁæ§
### Ch√©diak-Higashi Syndrome / Ch√©diak-HigashiÁóáÂÄôÁæ§
### Chronic Granulomatous Disease / ÊÖ¢ÊÄßËÇâËäΩËÖ´Áóá

## Neurological Disease / Á•ûÁµåÁñæÊÇ£

### Craniosynostosis / È†≠ËìãÁ∏´ÂêàÊó©ÊúüÁôíÂêàÁóá
### Spina Bifida / ‰∫åÂàÜËÑäÊ§é
### Cranium Bifidum / ‰∫åÂàÜÈ†≠Ëìã
### Congenital Hydrocephalus / ÂÖàÂ§©ÊÄßÊ∞¥È†≠Áóá
### Chiari Malformation / ChiariÂ•áÂΩ¢
### Dandy-Walker Syndrome / Dandy-WalkerÁóáÂÄôÁæ§
### Arachnoid Cyst / „Åè„ÇÇËÜúÂö¢ËÉû

## Neoplasm / Êñ∞ÁîüÁâ©

### Hepatoblastoma / ËÇùËäΩËÖ´
### Wilms' Tumor / WilmsËÖ´Áòç -->

<!-- # Emergency Medicine / ÊïëÊÄ•Áßë

## Shock / „Ç∑„Éß„ÉÉ„ÇØ

### Cardiopulmonary Arrest / ÂøÉËÇ∫ÂÅúÊ≠¢
### Hypovolemic Shock / Âæ™Áí∞Ë°ÄÊ∂≤ÈáèÊ∏õÂ∞ëÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Anaphylactic Shock / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº„Ç∑„Éß„ÉÉ„ÇØ
### Neurogenic Shock / Á•ûÁµåÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Septic Shock / ÊïóË°ÄÁóáÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Cardiogenic Shock / ÂøÉÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Extracardiac Obstructive Shock / ÂøÉÂ§ñÈñâÂ°ûÊÄß„Ç∑„Éß„ÉÉ„ÇØ

## Emergency Disease / ÊïëÊÄ•ÁñæÊÇ£

### Airway Foreign Body / Ê∞óÈÅìÁï∞Áâ©
### Gastrointestinal Foreign Body / Ê∂àÂåñÁÆ°Áï∞Áâ©
### Status Epilepticus / „Å¶„Çì„Åã„ÇìÈáçÁ©çÁä∂ÊÖã
### Acute Abdomen / ÊÄ•ÊÄßËÖπÁóá
### Multiple Organ Dysfunction Syndrome / Â§öËáìÂô®‰∏çÂÖ®

## Thoracic Injury / ËÉ∏ÈÉ®Â§ñÂÇ∑

### Tracheobronchial Injury / Ê∞óÁÆ°„ÉªÊ∞óÁÆ°ÊîØÊêçÂÇ∑
### Pulmonary Contusion / ËÇ∫Êå´ÂÇ∑
### Flail Chest / ËÉ∏ÈÉ≠ÂãïÊè∫
### Open Pneumothorax / ÈñãÊîæÊÄßÊ∞óËÉ∏
### Tension Pneumothorax / Á∑äÂºµÊÄßÊ∞óËÉ∏
### Aortic Injury / Â§ßÂãïËÑàÊêçÂÇ∑
### Massive Hemothorax / Â§ßÈáèË°ÄËÉ∏

## Abdominal Injury / ËÖπÈÉ®Â§ñÂÇ∑

### Liver Injury / ËÇùÊêçÂÇ∑
### Splenic Rupture / ËÑæÁ†¥Ë£Ç
### Kidney Injury / ËÖéÂ§ñÂÇ∑
### Urethral Injury / Â∞øÈÅìÂ§ñÂÇ∑
### Bladder Injury / ËÜÄËÉ±Â§ñÂÇ∑
### Testicular Injury / Á≤æÂ∑£Â§ñÂÇ∑

## Other Injury / „Åù„ÅÆ‰ªñ„ÅÆÂ§ñÂÇ∑

### High Energy Trauma / È´ò„Ç®„Éç„É´„ÇÆ„ÉºÂ§ñÂÇ∑
### Crush Syndrome / ÂúßÊå´ÁóáÂÄôÁæ§
### Compartment Syndrome / „Ç≥„É≥„Éë„Éº„Éà„É°„É≥„ÉàÁóáÂÄôÁæ§
### Fat Embolism Syndrome / ËÑÇËÇ™Â°ûÊ†ìÁóáÂÄôÁæ§
### Burns / ÁÜ±ÂÇ∑
### Smoke Inhalation Injury / Ê∞óÈÅìÁÜ±ÂÇ∑

## Diseases due to Physical Factors / Áâ©ÁêÜÁöÑË¶ÅÂõ†„Å´„Çà„ÇãÁñæÊÇ£

### Heat Illness / ÁÜ±‰∏≠Áóá
### Accidental Hypothermia / ÂÅ∂Áô∫ÊÄß‰Ωé‰ΩìÊ∏©Áóá
### Altitude Sickness / È´òÂ±±ÁóÖ
### Decompression Sickness / Ê∏õÂúßÁóá

## Poisoning / ‰∏≠ÊØí

### Food Poisoning / È£ü‰∏≠ÊØí
### Drug Poisoning / Ëñ¨Áâ©‰∏≠ÊØí
### Organic Solvent Poisoning / ÊúâÊ©üÊ∫∂Ââ§‰∏≠ÊØí
### Toxic Gas Poisoning / ÊúâÊØí„Ç¨„Çπ‰∏≠ÊØí
### Metal Poisoning / ÈáëÂ±û‰∏≠ÊØí
### Pesticide Poisoning / Ëæ≤Ëñ¨‰∏≠ÊØí -->

